Monoamine oxidase A inhibitors

MAOI_A

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Medicine purchases: ATC — N06AG 1 out of 7 registries used, show all original rules.	5335
4. Check minimum number of events Min. number of events 3	5335
5. Include endpoints None	5335
6. Filter based on genotype QC (FinnGen only)	5223

Control definitions (FinnGen only)

Control exclude: ANTIDEPRESSANTS

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	MAOI_A
CONTROL_EXCLUDE	ANTIDEPRESSANTS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC	N06AG
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Monoamine oxidase A inhibitors based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Not enough data for upset plot.

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	5223	3168	2055
Unadjusted period prevalence (%)	1.05	1.12	0.94
Median age at first event (years)	44.40	43.51	45.76

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
5335: Matched controls
53350

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

6.9

320.0

522

824

N06AA22, ,

ATC

149.0

318.9

159

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

89.6

314.5

165

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

25.2

312.3

220

N06AB05

ATC

paroxetine; oral

54.9

307.7

984

219

P01

ICPC

Feeling anxious/nervous/tense

7.2

307.7

821

1315

N06AB10

ATC

escitalopram; oral

29.2

307.7

2113

1172

N06AX17

ATC

milnacipran; oral

168.1

307.7

210

P29

ICPC

Psychological sympt/compl other

8.6

307.7

552

710

N05AA02

ATC

levomepromazine; systemic

27.1

307.7

574

236

N06AX26

ATC

vortioxetine; oral

81.6

307.7

892

131

N05AB03

ATC

perphenazine; systemic, rectal

24.4

307.7

529

240

SPAT1240

SPAT

Therapeutic discussion

6.4

307.7

738

1301

N05BA12

ATC

alprazolam; oral

19.3

307.7

1525

1084

F32.9

ICD-10 Finland

Depressive episode, unspecified

27.2

307.7

1493

751

N05BA02

ATC

chlordiazepoxide; systemic

23.7

307.7

311

139

F32.1

ICD-10 Finland

Moderate depressive episode

22.1

307.7

593

300

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

88.5

307.7

245

N06AX12

ATC

bupropion; oral

81.3

307.7

984

148

N03AE01

ATC

clonazepam; systemic

11.2

307.7

674

680

N03AG01

ATC

valproic acid; systemic, rectal

11.2

307.7

635

638

N05CF01

ATC

zopiclone; oral

6.6

307.7

2734

7374

N06AB04

ATC

citalopram; systemic

39.6

307.7

2668

1315

F41.1

ICD-10 Finland

Generalized anxiety disorder

22.7

307.7

521

253

P74

ICPC

Anxiety disorder/anxiety state

15.6

307.7

362

248

N03AX09

ATC

lamotrigine; oral

30.0

307.7

642

242

N06AB03

ATC

fluoxetine; oral

45.6

307.7

1957

669

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

20.9

307.7

349

178

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

8.4

307.7

769

1053

N06AG02

ATC

moclobemide; oral

+∞

307.7

5335

157

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

169.0

307.7

653

F33

ICD-10 Finland

Recurrent depressive disorder

109.7

307.7

231

T36

ICD-10 Finland

Poisoning by systemic antibiotics

19.2

307.7

473

269

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

96.3

307.7

186

N06AX22

ATC

agomelatine; oral

162.0

307.7

320

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

11.7

307.7

787

780

F40.1

ICD-10 Finland

Social phobias

56.8

307.7

400

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

12.6

307.7

869

809

N06AA12

ATC

doxepin; systemic

30.2

307.7

701

266

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

162.0

307.7

925

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

177.5

307.7

333

N05AX08

ATC

risperidone; systemic

10.4

307.7

770

848

N05AN01

ATC

lithium; oral

38.7

307.7

375

104

N05AL01

ATC

sulpiride; systemic

61.4

307.7

285

F51.0

ICD-10 Finland

Nonorganic insomnia

4.7

307.7

1054

2680

N06AX18

ATC

reboxetine; oral

289.9

307.7

301

N07BB01

ATC

disulfiram; oral

12.4

307.7

401

348

N06AB08

ATC

fluvoxamine; oral

81.3

307.7

535

N06AA06

ATC

trimipramine; systemic

46.8

307.7

379

N06AA09

ATC

amitriptyline; systemic

10.4

307.7

918

1048

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

89.2

307.7

319

N05AF03

ATC

chlorprothixene; systemic

37.5

307.7

403

116

C07AA05

ATC

propranolol; systemic

5.4

307.7

1817

4627

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

85.7

307.7

222

N05BA01

ATC

diazepam; systemic, rectal

10.2

307.7

1532

2030

P99

ICPC

Psychological disorders other

17.7

307.7

272

161

F31.8

ICD-10 Finland

Other bipolar affective disorders

58.0

307.7

201

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

16.0

307.7

366

244

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

111.1

307.7

304

F32

ICD-10 Finland

Depressive episode

27.0

307.7

519

212

F34.1

ICD-10 Finland

Dysthymia

110.1

307.7

623

N06AB06

ATC

sertraline; oral

55.5

307.7

1633

421

N05CD07

ATC

temazepam; oral

13.4

307.7

1452

1448

N06AX16

ATC

venlafaxine; oral

65.4

307.7

2056

507

N06AX11

ATC

mirtazapine; oral

13.9

307.7

3105

4854

N05BA04

ATC

oxazepam; oral

12.0

307.7

2761

4363

N05AH04

ATC

quetiapine; oral

19.2

307.7

2033

1654

N06CA01

ATC

amitriptyline and psycholeptics; systemic

7.6

307.7

1004

1589

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

19.0

307.7

983

627

N06AA04

ATC

clomipramine; systemic

84.6

307.7

296

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

48.7

307.7

325

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

345.4

307.7

819

N05BE01

ATC

buspirone; oral

79.2

307.7

630

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

44.9

307.7

232

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

146.6

307.7

184

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

23.4

307.7

299

135

N05AX12

ATC

aripiprazole; systemic

32.9

307.7

494

165

P76

ICPC

Depressive disorder

31.8

307.7

712

257

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

31.2

307.7

287

P03

ICPC

Feeling depressed

14.0

307.7

874

734

N06AX03

ATC

mianserin; oral

82.4

307.7

967

143

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

74.2

307.7

908

147

N06AX21

ATC

duloxetine; oral

23.2

307.7

1322

748

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

100.1

307.7

441

N05BA06

ATC

lorazepam; systemic, sublingual

13.8

307.7

588

473

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

29.4

307.7

923

377

N05CF02

ATC

zolpidem; oral

5.2

307.7

1395

3372

N05AF01

ATC

flupentixol; systemic

49.9

307.7

328

N05AH03

ATC

olanzapine; systemic

18.0

307.7

730

465

F61.0

ICD-10 Finland

Mixed personality disorders

111.5

307.7

275

N06AX05

ATC

trazodone; oral

87.1

307.7

388

IGY02

NOMESCO Finland

Psychiatric monitoring contact

19.8

307.0

239

126

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

21.9

302.2

225

107

N03AX16

ATC

[U] pregabalin

3.2

301.4

1568

6088

F60.9

ICD-10 Finland

Personality disorder, unspecified

47.0

295.4

173

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

26.0

291.9

203

F41.09

ICD-10 Finland

UNS Panic Syndrome

19.1

283.4

224

122

ZY010

NOMESCO Finland

Hospital outpatient

7.3

280.2

432

640

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

61.0

277.0

154

N05CD02

ATC

nitrazepam; oral

18.7

274.1

219

122

IGY99

NOMESCO Finland

Other psychiatric treatment contact

29.0

264.7

177

2961C

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]

100.4

264.6

137

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

45.6

262.9

155

F31

ICD-10 Finland

Bipolar affective disorder

49.4

257.3

149

F41.00

ICD-10 Finland

Moderate panic disorder

45.5

247.5

146

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

31.7

241.6

157

F10.20

ICD-10 Finland

Alcohol dependence currently independent

18.9

239.6

190

104

N05AB01

ATC

dixyrazine; systemic

29.2

238.4

159

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

24.9

232.2

164

N05AC02

ATC

thioridazine; oral

14.3

225.1

206

149

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

30.4

224.9

148

R53

ICD-10 Finland

Malaise and fatigue

2.8

222.6

1402

5932

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

12.1

221.8

225

193

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

13.2

216.8

208

163

P06

ICPC

Sleep disturbance

3.7

215.5

756

2252

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

70.3

215.5

117

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

12.8

214.6

210

170

Z2445

NOMESCO Finland

Psychologist

7.9

212.1

299

399

A06AC01

ATC

ispaghula (psylla seeds); oral

2.6

209.7

1647

7763

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

41.6

209.2

126

SPAT1307

SPAT

Psychosocial counselling and guidance

6.5

209.0

355

580

N05BA05

ATC

potassium clorazepate; oral

27.6

206.1

140

V03AA01, ,

ATC

17.2

205.0

170

102

F33.0

ICD-10 Finland

Recurrent depressive disorder, current episode mild

58.2

203.3

114

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

16.7

202.0

170

105

F99

ICD-10 Finland

Mental disorder, not otherwise specified

14.8

201.9

181

126

IHZ05, ,

SPAT

9.5

195.5

235

257

N06BA04

ATC

methylphenidate; oral

13.3

194.4

186

145

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.4

192.4

777

2529

SPAT1243

SPAT

Psychiatric/psychological examination

13.2

191.8

184

144

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

5.0

189.8

430

917

F32.8

ICD-10 Finland

Other depressive episodes

22.1

189.5

140

F60.5

ICD-10 Finland

Anankastic personality disorder

44.0

188.4

112

2961D

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN]

73.5

187.2

101

F41.8

ICD-10 Finland

Other specified anxiety disorders

10.6

186.1

206

201

F29

ICD-10 Finland

Unspecified nonorganic psychosis

8.4

185.0

245

303

N03AX12

ATC

[U] gabapentin; oral

3.0

183.8

984

3776

A03CA02

ATC

clidinium and psycholeptics; oral

4.6

179.2

458

1077

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

23.4

177.3

128

N05AD03

ATC

melperone; systemic

17.0

176.3

147

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

22.2

176.3

130

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

6.3

169.4

292

483

A02BA02

ATC

ranitidine; systemic

2.6

167.6

1195

5299

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

6.7

167.1

271

421

Z2446

NOMESCO Finland

Social worker

4.4

166.6

442

1069

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

20.8

166.3

126

N06AA10

ATC

nortriptyline; systemic

11.8

165.0

170

149

G47.3

ICD-10 Finland

Sleep apnoea

2.5

164.6

1370

6529

N04AA02

ATC

biperiden; systemic

12.9

164.5

160

128

A06AD11

ATC

lactulose; oral

3.0

161.7

837

3137

F39

ICD-10 Finland

Unspecified mood [affective] disorder

16.7

160.6

135

P15

ICPC

Chronic alcohol abuse

8.1

149.6

204

261

A02BC01

ATC

omeprazole; systemic

2.3

149.3

1571

8246

N05AA01

ATC

chlorpromazine; systemic, rectal

16.2

149.2

127

F10.24

ICD-10 Finland

Alcohol depence active use

16.8

146.1

122

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

15.2

145.4

128

A04

ICPC

Weakness/tiredness general

2.8

140.8

815

3230

F90.0

ICD-10 Finland

Disturbance of activity and attention

9.2

137.7

168

187

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

30.5

137.0

N02AX02

ATC

tramadol; systemic, rectal

2.0

136.1

2352

14834

V03AB30, ,

ATC

30.8

134.4

A03FA02

ATC

cisapride; oral, rectal

3.5

134.3

507

1567

F60.8

ICD-10 Finland

Other specific personality disorders

55.1

134.0

M79.7

ICD-10 Finland

Fibromyalgia

6.6

133.0

219

345

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

13.0

132.6

128

101

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

158.5

132.0

139

A02BC03

ATC

lansoprazole; oral

2.2

131.9

1639

9121

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

4.4

130.9

346

832

N05AB02

ATC

fluphenazine; systemic

25.4

128.8

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.3

128.4

1313

6749

N02BF02

ATC

pregabalin; oral

4.2

127.9

361

912

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

22.5

127.0

F32.0

ICD-10 Finland

Mild depressive episode

9.5

126.9

152

165

F41.3

ICD-10 Finland

Other mixed anxiety disorders

16.7

125.4

105

R06.0

ICD-10 Finland

Dyspnoea

2.2

124.8

1477

8037

N03AX11

ATC

topiramate; oral

7.7

124.7

177

237

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

25.7

123.5

F10.25

ICD-10 Finland

Alcohol dependence continuous use

11.2

122.5

130

119

N03AF01

ATC

carbamazepine; oral, rectal

4.3

122.4

331

809

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.0

122.0

1973

12032

M79.0

ICD-10 Finland

Rheumatism, unspecified

5.9

121.6

223

391

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

12.0

120.4

122

104

A02BC02

ATC

pantoprazole; systemic

2.0

120.1

3667

27734

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

3.1

119.9

537

1839

H03AA01

ATC

levothyroxine sodium; systemic

2.2

119.6

1362

7283

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

209.8

119.1

123

IGY02, ,

SPAT

18.7

118.7

M01AE03

ATC

ketoprofen; systemic, rectal

2.0

117.7

2053

12815

Z3231

NOMESCO Finland

Registered nurse

2.1

117.3

1511

8459

N06AC02, ,

ATC

59.8

116.3

F43.1

ICD-10 Finland

Post-traumatic stress disorder

8.7

115.3

147

173

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

5.0

114.0

254

531

A02BC05

ATC

esomeprazole; systemic

1.9

113.7

2237

14502

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

33.2

112.4

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

3.8

111.9

361

1002

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

9.1

111.7

138

156

ZY000

NOMESCO Finland

Hospital inpatient

13.8

110.9

103

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

23.2

110.6

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

15.8

110.4

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.0

108.8

1567

9096

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

31.8

106.3

Z2221

NOMESCO Finland

Medical doctor

2.0

106.3

1531

8876

N05CD08

ATC

midazolam; nasal, systemic

6.5

105.6

174

274

R03AC02

ATC

salbutamol; inhalant

1.9

104.4

2889

20704

F40.01

ICD-10 Finland

Agoraphobia with concomitant panic disorder

54.2

103.6

AA400

NOMESCO Finland

Electroconvulsive therapy

158.9

103.6

109

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

26.6

103.3

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

7.4

102.9

150

207

A02BA04

ATC

nizatidine; systemic

3.1

102.4

468

1617

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

31.8

101.7

3004A

ICD-9 Finland

Neurotic disorders, Neurotic depression

39.2

101.3

R4140

NOMESCO Finland

Psychotherapy

35.4

100.2

J02AC01

ATC

fluconazole; systemic

1.9

100.1

2153

14204

ZXY01

NOMESCO Finland

Chief Physician, Head of Department or Deputy Chief Physician

30.8

97.7

F60.7

ICD-10 Finland

Dependent personality disorder

48.0

97.6

R07.4

ICD-10 Finland

Chest pain, unspecified

2.0

97.3

1517

8993

N05AD01

ATC

haloperidol; systemic

5.6

96.7

188

348

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

21.5

96.5

M03BX02

ATC

tizanidine; oral

1.8

95.1

3312

25162

9690A

ICD-9 Finland

Poisoning by psychotropic agents, Antidepressants

43.5

93.8

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

22.9

93.6

N05AC01

ATC

periciazine; systemic

30.8

93.1

C07AB07

ATC

bisoprolol; oral

1.8

93.0

2480

17354

F33.8

ICD-10 Finland

Other recurrent depressive disorders

241.7

92.9

188

Kela drug reimbursment

Psychosis requiring demanding treatment

13.4

92.1

AA1AD

NOMESCO Finland

CT of head and brain

2.0

92.0

1367

7948

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

18.5

91.6

IER01

NOMESCO Finland

Psychoeducation, group

30.3

91.1

Z3226

NOMESCO Finland

Physiotherapist

2.1

91.1

989

5128

IBA03

NOMESCO Finland

Psychotherapy evaluation

23.0

91.0

Z71.8

ICD-10 Finland

Other specified counselling

1.9

90.7

1617

9979

L28

ICPC

Limited function/disability (L)

2.2

89.7

886

4423

N05CD05

ATC

triazolam; oral, sublingual

9.9

88.5

102

105

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

9.4

88.5

106

115

P16

ICPC

Acute alcohol abuse

9.2

87.3

106

117

IHZ04, ,

SPAT

15.8

87.2

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

3.4

86.7

331

1024

F41.01

ICD-10 Finland

Severe panic disorder

50.5

86.4

P25

ICPC

Phase of life problem adult

4.4

86.1

223

526

N05AH02

ATC

clozapine; systemic

9.0

85.6

106

120

F42.2

ICD-10 Finland

Mixed obsessional thoughts and acts

49.4

84.3

M01AG02

ATC

tolfenamic acid; oral, rectal

2.2

84.1

828

4120

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.8

84.1

2307

16125

M03BC51

ATC

orphenadrine, combinations; systemic

1.9

84.1

1451

8823

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

3.4

84.1

312

948

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

42.1

83.0

R42

ICD-10 Finland

Dizziness and giddiness

2.0

82.8

1177

6707

G04BD04

ATC

oxybutynin; oral, transdermal

3.4

82.4

305

925

A01

ICPC

Pain general/multiple sites

2.7

82.2

497

1988

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

18.8

82.2

IEY01

NOMESCO Finland

Psychoeducation, individual

30.3

81.9

R5140

NOMESCO Finland

Monitoring the use of the aid

2.4

81.8

619

2754

ZYC01

NOMESCO Finland

Remote contact by phone

3.1

81.8

355

1187

P01AB01

ATC

metronidazole; oral, rectal

1.8

81.7

2103

14400

G44.2

ICD-10 Finland

Tension-type headache

2.3

81.7

720

3422

N04BC05

ATC

pramipexole; oral

2.9

80.8

411

1503

R51.80

ICD-10 Finland

Headache

2.2

80.3

771

3794

IGV01

NOMESCO Finland

Psychiatric network contact

24.0

79.8

P28

ICPC

Limited function/disability (P)

15.1

79.3

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

9.3

78.7

104

A03FA01

ATC

metoclopramide; systemic, rectal

1.9

78.5

1182

6851

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

3.1

78.3

350

1190

P73

ICPC

Affective psychosis

29.2

77.9

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.0

76.7

354

1225

J45.9

ICD-10 Finland

Asthma, unspecified

2.0

76.7

979

5357

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.6

76.6

493

2031

309

Kela drug reimbursment

Nalmefene and naltrexone

33.0

76.2

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

3.0

76.2

360

1263

F61

ICD-10 Finland

Mixed and other personality disorders

94.9

76.1

M79.6

ICD-10 Finland

Pain in limb

1.7

75.5

2143

14988

R06AE07

ATC

cetirizine; oral

1.7

75.5

2266

16091

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.6

75.0

451

1797

F42.1

ICD-10 Finland

Predominantly compulsive acts [obsessional rituals]

38.7

74.7

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

158.3

74.2

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

92.6

74.1

M54.5

ICD-10 Finland

Low back pain

1.7

74.1

1785

11915

L03

ICPC

Low back symptom/complaint

1.8

73.9

1388

8611

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.5

73.9

488

2035

E66.8

ICD-10 Finland

Other obesity

3.2

73.8

303

979

SPAT1234

SPAT

Support of social functional capacity

3.6

73.2

245

695

IBZ02

NOMESCO Finland

Somatic assessment of psychiatric patient

30.3

72.8

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

9.7

71.9

N02AJ06

ATC

codeine and paracetamol; systemic

1.7

71.7

2142

15130

ZXD10

NOMESCO Finland

Scheduled procedure

1.7

71.7

1980

13695

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

11.7

71.4

J01DA01

ATC

[U] cefalexin

1.7

70.9

3192

25062

C03CA01

ATC

furosemide; systemic

1.8

70.6

1375

8606

F21

ICD-10 Finland

Schizotypal disorder

20.2

70.5

XF400

NOMESCO Finland

ECG with 12 standard connections

2.1

70.1

790

4121

M01AE02

ATC

naproxen; oral, rectal

1.7

69.9

2874

22009

L01

ICPC

Neck symptom/complaint

2.0

68.9

809

4282

X61

ICD-10 Finland

Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified

36.1

68.6

F60.6

ICD-10 Finland

Anxious [avoidant] personality disorder

236.4

68.4

R06.5

ICD-10 Finland

Mouth breathing

2.4

68.4

503

2202

ZXE00

NOMESCO Finland

One hour or less

1.7

68.4

1959

13639

K59.0

ICD-10 Finland

Constipation

3.1

68.3

298

998

E66.01

ICD-10 Finland

Obesity due to excess calories

2.5

67.8

457

1921

ZXE10

NOMESCO Finland

More than one and less than three hours

1.7

67.8

1833

12560

SPAT1241

SPAT

Extensive assessment of psychosocial situation

12.3

67.6

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.1

67.1

709

3605

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

6.2

66.9

115

189

F10.09

ICD-10 Finland

Alcohol intoxication UNS

6.0

66.2

118

201

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

5.8

65.9

121

212

30041

ICD-8 Finland

Neuroses, Depressiva

8.5

65.6

102

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.6

64.7

2201

15954

R02

ICPC

Shortness of breath/dyspnoea

2.1

64.7

658

3295

P72

ICPC

Schizophrenia

6.6

64.6

105

163

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

4.7

64.4

149

321

N02BF01

ATC

gabapentin; oral

2.6

64.3

413

1696

WX110

NOMESCO Finland

Infiltration anesthesia

1.7

64.0

3604

29584

P20

ICPC

Memory disturbance

2.2

64.0

602

2923

N02BE01

ATC

paracetamol; systemic, rectal

2.0

63.3

4630

40895

T82

ICPC

Obesity

3.5

63.1

227

675

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

6.1

62.4

109

182

D01

ICPC

Abdominal pain/cramps general

2.2

62.3

590

2871

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

62.3

1155

7086

D11

ICPC

Diarrhoea

2.2

62.2

574

2764

M03BC01

ATC

orphenadrine (citrate); systemic

1.8

62.1

1146

7019

SFA10

NOMESCO Finland

One-surface restoration

1.6

61.9

2757

21275

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.1

61.8

650

3294

R01AD09

ATC

mometasone; nasal

1.6

61.6

2279

16806

SAA01

NOMESCO Finland

Simple examination of mouth

1.7

61.5

3618

29863

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.1

61.2

667

3424

F20.9

ICD-10 Finland

Schizophrenia, unspecified

5.9

61.2

110

189

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.9

61.1

303

1090

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

26.5

60.8

R52.2

ICD-10 Finland

Other chronic pain

3.7

60.7

194

533

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

209.1

60.2

R06AX13

ATC

loratadine; oral

2.0

59.9

782

4282

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

2.3

59.8

482

2192

A01AB09

ATC

miconazole; local oral

2.4

59.6

448

1976

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.9

59.6

840

4719

WX290

NOMESCO Finland

Other blockage of nerve

1.6

59.4

2268

16805

R4110

NOMESCO Finland

Physiotherapy

1.7

59.4

1411

9270

UJF32

NOMESCO Finland

Coloscopy

1.7

59.3

1310

8437

F41

ICD-10 Finland

Other anxiety disorders

6.9

59.2

133

G04BD07

ATC

tolterodine; oral

3.1

59.0

260

875

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

5.7

58.8

109

193

E0000UV, ,

ATC

1.6

58.7

2059

14937

R03BB04

ATC

tiotropium bromide; inhalant

2.3

58.4

486

2240

G04BD12

ATC

mirabegron; oral

2.1

58.3

581

2880

S06.0

ICD-10 Finland

Concussion

2.2

58.3

513

2420

L17

ICPC

Foot/toe symptom/complaint

1.7

58.3

1421

9393

J01MA02

ATC

ciprofloxacin; systemic

1.6

58.3

1907

13595

N05AE04

ATC

ziprasidone; systemic

82.3

58.0

F33.01

ICD-10 Finland

Recurrent depression, mild episode of somatic syndrome

125.5

57.9

L02

ICPC

Back symptom/complaint

2.2

57.3

499

2343

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.9

57.3

878

5063

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.5

57.3

378

1571

Z63.0

ICD-10 Finland

Problems in relationship with spouse or partner

9.8

57.2

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

73.2

57.2

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

9.4

57.2

R01AD08

ATC

fluticasone; nasal

1.7

57.1

1444

9631

J01EA01

ATC

trimethoprim; systemic

1.7

57.1

1277

8240

ZXY49

NOMESCO Finland

Other health care provider

25.2

56.9

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.1

56.7

638

3309

J01FA06

ATC

roxithromycin; oral

1.6

56.3

2001

14521

J01AA02

ATC

doxycycline; systemic

1.7

56.2

4018

34384

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

121.4

55.9

R01BA52

ATC

pseudoephedrine, combinations; oral

1.7

55.8

1569

10742

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

10.3

55.5

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.6

55.5

2220

16551

SPAT1246

SPAT

Screening of depression or other psychiatric problem

3.8

55.4

170

454

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.7

55.3

1376

9124

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

55.1

2233

16687

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

8.5

54.9

A28

ICPC

Limited function/disability NOS

2.0

54.9

725

3978

R03BA02

ATC

budesonide; inhalant

1.8

54.6

894

5257

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

54.6

2017

14743

R25.1

ICD-10 Finland

Tremor, unspecified

3.6

54.6

181

510

K02.1

ICD-10 Finland

Caries of dentine

1.6

54.2

2889

22948

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.7

54.2

1453

9816

A97

ICPC

No disease

1.8

53.5

874

5135

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.6

53.3

2314

17525

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.7

52.7

1131

7193

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.5

52.6

353

1477

Z01.2

ICD-10 Finland

Dental examination

1.6

52.4

2244

16925

C05AA08

ATC

fluocortolone; rectal, topical

1.9

52.2

715

3966

A06AC51

ATC

ispaghula, combinations; oral

2.8

52.0

265

966

A07DA03

ATC

loperamide; oral

3.3

52.0

200

620

M01AH01

ATC

celecoxib; oral

1.8

52.0

896

5346

SPAT1235

SPAT

Mental health, emotional support

15.0

51.9

C07AB02

ATC

metoprolol; systemic

1.8

51.7

934

5650

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

51.7

1409

9538

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.7

51.6

1361

9136

F51

ICD-10 Finland

Nonorganic sleep disorders

3.5

51.6

184

544

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.2

51.5

492

2395

H02AB06

ATC

prednisolone; systemic

1.6

51.4

2338

17844

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.5

51.3

2749

21753

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

136.4

50.9

M02AA07

ATC

piroxicam; topical

1.6

50.7

1788

12872

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.2

50.6

461

2201

M01AB05

ATC

diclofenac; systemic, rectal

1.6

50.5

3364

27882

R35

ICD-10 Finland

Polyuria

2.5

50.5

338

1413

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

9.2

50.4

R52.9

ICD-10 Finland

Pain, unspecified

2.1

50.4

492

2415

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

50.2

1656

11730

R03AC03

ATC

terbutaline; inhalant

1.9

50.2

702

3919

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

7.6

50.0

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

12.0

49.7

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

2.0

49.5

602

3203

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

20.1

49.5

N05AF05

ATC

zuclopenthixol; systemic

8.9

49.3

R03DC03

ATC

montelukast; oral

1.8

49.1

828

4901

J01MA06

ATC

norfloxacin; oral

1.9

49.0

678

3768

M01AX17

ATC

nimesulide; oral

1.7

49.0

1185

7762

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

49.0

1861

13603

SFA20

NOMESCO Finland

Two-surface restoration

1.5

48.9

2907

23419

EBA00

NOMESCO Finland

Extraction of tooth

1.6

48.8

1670

11915

A10BA02

ATC

metformin; oral

1.6

48.6

1323

8929

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.2

48.6

439

2089

A02BA03

ATC

famotidine; systemic

3.1

48.6

211

704

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.9

48.5

743

4267

P27

ICPC

Fear of mental disorder

9.3

48.3

SPAT1238

SPAT

Brief therapy

6.7

48.3

114

N17

ICPC

Vertigo/dizziness

2.0

48.3

578

3057

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

7.3

48.2

G04CA02

ATC

tamsulosin; oral

1.7

48.2

975

6083

30040

ICD-8 Finland

Neuroses, Neurotico-depressiva

11.8

48.1

M54.4

ICD-10 Finland

Lumbago with sciatica

1.8

47.9

844

5059

S01GX01

ATC

cromoglicic acid; ophthalmic

1.7

47.7

979

6129

E66.9

ICD-10 Finland

Obesity, unspecified

3.3

47.6

185

577

R06AX22

ATC

ebastine; oral

1.8

47.3

860

5200

N01

ICPC

Headache

2.1

47.2

463

2274

L08

ICPC

Shoulder symptom/complaint

1.7

47.2

1084

6995

IHZ07, ,

SPAT

13.0

46.8

N02AC04

ATC

dextropropoxyphene; oral

3.2

46.7

185

584

A02BX02

ATC

sucralfate; oral

3.0

46.6

210

715

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

46.6

1371

9416

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.8

46.5

813

4858

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

2.4

46.4

348

1530

T90

ICPC

Diabetes non-insulin dependent

1.7

45.9

1130

7418

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

45.9

3252

27023

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

13.5

45.9

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.9

45.8

660

3712

F22.0

ICD-10 Finland

Delusional disorder

5.6

45.7

158

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.7

45.5

929

5799

2961E

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN+PSYKOOT PIIRTEI]

59.5

45.4

S29

ICPC

Skin symptom/complaint other

1.7

45.3

928

5798

Z08

ICPC

Social welfare problem

7.1

45.3

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.6

45.1

1240

8368

N02AA05

ATC

oxycodone; systemic

1.8

45.0

757

4468

R05FB02

ATC

cough suppressants and expectorants; systemic

1.5

45.0

1836

13571

J01DB01

ATC

cefalexin; oral

1.6

45.0

4190

36916

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.9

44.8

222

797

SCA01

NOMESCO Finland

Preventive oral health care, short

1.6

44.8

1328

9124

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

9.2

44.8

R07.3

ICD-10 Finland

Other chest pain

2.0

44.8

501

2584

G25.0

ICD-10 Finland

Essential tremor

3.5

44.3

153

443

KMAK, ,

NOMESCO Finland

1.5

44.2

2487

19642

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.8

44.0

725

4249

XA800

NOMESCO Finland

Neuropsychological investigation

2.9

43.9

209

734

103

Kela drug reimbursment

Diabetes, insulin-treated

1.6

43.8

1246

8467

J01AA07

ATC

tetracycline; systemic

1.8

43.8

714

4171

D12

ICPC

Constipation

3.2

43.8

178

571

E000001, ,

ATC

1.7

43.7

934

5899

R05

ICPC

Cough

1.6

43.6

1136

7553

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.7

43.6

1090

7173

F43.29

ICD-10 Finland

Adaptation disorder UNS

4.4

43.5

111

259

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.9

43.4

564

3063

SPAT1301

SPAT

No procedures

1.6

43.3

1416

9942

E66.00

ICD-10 Finland

Metabolic syndrome

2.5

43.3

288

1199

IGY99, ,

SPAT

7.6

43.3

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.6

43.2

1151

7694

R03BA05

ATC

fluticasone; inhalant

1.7

43.2

870

5405

M01AB55

ATC

diclofenac, combinations; oral

2.3

43.2

341

1533

SPAT1265

SPAT

Breathalyser

8.2

43.1

H04.10

ICD-10 Finland

Dry eye syndrome

1.9

42.9

573

3140

Z29

ICPC

Social problem NOS

4.7

42.9

100

217

N05AE05

ATC

lurasidone; oral

94.9

42.8

7290A

ICD-9 Finland

Other disorders of soft tissues, Rheumatism, unspecified and fibrositis

10.8

42.6

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.7

42.3

1034

6761

IFB02

NOMESCO Finland

Transcranial magnetic stimulation (TMS)

421.0

42.2

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.6

42.1

1153

7753

M54

ICD-10 Finland

Dorsalgia

1.9

42.1

575

3175

L15

ICPC

Knee symptom/complaint

1.6

42.0

1160

7816

R11

ICD-10 Finland

Nausea and vomiting

2.2

41.6

379

1806

P18

ICPC

Medication abuse

13.5

41.6

H02AB07

ATC

prednisone; oral

1.8

41.5

667

3876

R52.1

ICD-10 Finland

Chronic intractable pain

7.4

41.5

SFA30

NOMESCO Finland

Three-surface restoration

1.5

41.4

2082

16001

RS221, ,

NOMESCO Finland

5.2

41.4

169

F50.9

ICD-10 Finland

Eating disorder, unspecified

11.8

41.2

SPAT1252

SPAT

Overall medication plan or its review

2.3

41.1

314

1391

SPAT1254

SPAT

Administration of medicine

1.9

41.1

608

3443

K59.09

ICD-10 Finland

Constipation, unspecified

2.4

41.0

297

1285

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.6

41.0

1209

8271

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

40.8

1080

7195

F42.0

ICD-10 Finland

Predominantly obsessional thoughts or ruminations

110.9

40.8

P58

ICPC

Psychological, Therapeutic counselling/listening

5.0

40.8

179

K59.1

ICD-10 Finland

Functional diarrhoea

2.5

40.6

267

1105

A01AB04

ATC

amphotericin B; local oral

2.6

40.6

234

909

R03BA01

ATC

beclometasone; inhalant

1.8

40.5

679

3994

SPAT1053

SPAT

Memory test

1.9

40.5

594

3355

J01FA10

ATC

azithromycin; systemic

1.5

40.4

2792

22810

D07AA02

ATC

hydrocortisone; topical

1.8

40.2

637

3684

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.6

40.2

1028

6789

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

39.6

863

5464

M01AE51

ATC

ibuprofen, combinations; systemic

4.5

39.6

219

M01AC06

ATC

meloxicam; systemic, rectal

1.5

39.5

1771

13264

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

52.7

39.5

M70.6

ICD-10 Finland

Trochanteric bursitis

1.8

39.5

634

3680

A09

ICPC

Sweating problem

5.7

39.5

129

J01DA06

ATC

[U] cefuroxime

1.8

39.4

705

4227

UKC02

NOMESCO Finland

Cystoscopy

1.8

39.3

703

4213

M01AH02

ATC

rofecoxib; oral

1.8

39.3

602

3445

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.8

39.3

620

3581

F45.8

ICD-10 Finland

Other somatoform disorders

2.3

39.2

314

1419

N03AF02

ATC

oxcarbazepine; oral

3.2

39.0

158

506

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.1

38.9

389

1921

F43.21

ICD-10 Finland

Adaptation disorder with prolonged depression

9.5

38.9

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.8

38.8

204

756

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.8

38.7

660

3900

M25.5

ICD-10 Finland

Pain in joint

1.5

38.6

1521

11076

WZA90

NOMESCO Finland

Other medical or dental certificate

1.6

38.5

1080

7284

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.1

38.5

403

2025

M79.1

ICD-10 Finland

Myalgia

1.8

38.5

664

3936

Z02.7

ICD-10 Finland

Issue of medical certificate

2.3

38.4

314

1432

A07AA02

ATC

nystatin; oral

2.3

38.1

287

1264

R06AX27

ATC

desloratadine; oral

1.5

37.9

1330

9438

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.0

37.8

418

2143

G04BD08

ATC

solifenacin; oral

2.3

37.8

301

1357

N07BA03

ATC

varenicline; oral

2.6

37.6

226

896

A99

ICPC

Disease/condition unspecnature/site

2.0

37.6

436

2274

F45.0

ICD-10 Finland

Somatization disorder

15.1

37.4

Z72.2

ICD-10 Finland

Drug use

15.1

37.4

C10AA01

ATC

simvastatin; oral

1.5

37.4

1904

14591

XKD00

NOMESCO Finland

Uroflowmetry

1.8

37.4

661

3946

L29

ICPC

Musculoskeletal sympt/complt other

2.0

37.4

416

2138

G03DB01

ATC

dydrogesterone; oral

1.8

37.2

609

3553

-, ,

ICD-10 Finland

3.4

37.2

134

399

U02

ICPC

Urinary frequency/urgency

1.8

37.2

655

3905

Z72.1

ICD-10 Finland

Alcohol use

6.0

37.1

109

IAA01, ,

SPAT

11.2

37.1

F33.3

ICD-10 Finland

Recurrent depressive disorder, current episode severe with psychotic symptoms

370.0

37.0

K07.60

ICD-10 Finland

Snapping jaw

2.5

36.9

242

1000

R05

ICD-10 Finland

Cough

1.6

36.9

1030

6931

R96

ICPC

Asthma

2.0

36.8

456

2433

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.2

36.8

308

1418

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

12.0

36.8

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

36.7

1392

10035

R01AD01

ATC

beclometasone; nasal

1.7

36.7

743

4607

SPAT1227

SPAT

Substance abuse rehabilitation

13.0

36.5

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

36.4

1269

8983

K30

ICD-10 Finland

Functional dyspepsia

1.9

36.3

535

3020

M48.0

ICD-10 Finland

Spinal stenosis

1.9

36.1

533

3011

T83

ICPC

Overweight

3.7

36.1

114

311

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

36.0

965

6426

IBB03

NOMESCO Finland

Assessment of vocational rehabilitation needs in a mental health context

359.8

36.0

N05BB01

ATC

hydroxyzine; systemic

2.2

35.9

300

1380

S18

ICPC

Laceration/cut

1.4

35.7

2155

17014

TAB00

NOMESCO Finland

Lumbar puncture

2.6

35.7

211

830

N05AB04

ATC

prochlorperazine; systemic, rectal

3.5

35.6

124

361

IAB01, ,

SPAT

48.1

35.6

SPAT1310

SPAT

Counselling related to known health issue

1.5

35.6

1425

10381

D07AC01

ATC

betamethasone; topical

1.5

35.6

1717

12989

R74

ICPC

Upper respiratory infection acute

1.5

35.4

1393

10108

R20.2

ICD-10 Finland

Paraesthesia of skin

2.1

35.3

339

1649

SPAT1260

SPAT

Consultation of another employee

1.7

35.2

788

5014

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

5.2

35.1

140

N30.0

ICD-10 Finland

Acute cystitis

1.7

35.1

715

4436

R21

ICPC

Throat symptom/complaint

1.6

35.0

890

5847

N06BA12

ATC

lisdexamfetamine; oral

12.1

35.0

P80

ICPC

Personality disorder

67.1

35.0

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.9

34.9

168

594

R60.0

ICD-10 Finland

Localized oedema

1.8

34.9

564

3275

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

34.6

1153

8065

J01CA04

ATC

amoxicillin; systemic

1.5

34.6

4048

36056

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.7

34.5

728

4557

-1, ,

NOMESCO Finland

1.5

34.2

1495

11071

3090A

ICD-9 Finland

Adjustment reaction, Brief depressive reaction

12.2

34.1

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

2.4

34.1

242

1037

U04

ICPC

Incontinence urine

2.4

34.1

233

982

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

5.2

34.0

133

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

33.9

858

5627

F13.24

ICD-10 Finland

Addiction relationship caused by sedative and hypnotic active addiction

76.7

33.8

SPAT1216

SPAT

Assessment of functional ability

1.7

33.7

635

3852

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

33.7

3293

28248

R05FA02

ATC

opium derivatives and expectorants; systemic

1.4

33.7

1895

14723

G47.9

ICD-10 Finland

Sleep disorder, unspecified

3.3

33.6

130

405

WZC00

NOMESCO Finland

Treatment plan or consultation

1.5

33.6

1684

12802

R06AX26

ATC

fexofenadine; oral

2.1

33.5

342

1701

R41.0

ICD-10 Finland

Disorientation, unspecified

3.3

33.5

125

381

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.9

33.4

421

2257

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.5

33.4

1272

9151

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.7

33.3

182

688

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

33.0

2194

17551

R01AD05

ATC

budesonide; nasal

2.0

33.0

377

1954

E66

ICD-10 Finland

Obesity

2.4

32.9

244

1066

XKD03

NOMESCO Finland

Urethral pressure profilometry

3.4

32.9

121

365

SPAT1229

SPAT

Assessment of need for aid

2.1

32.8

325

1599

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.4

32.8

230

981

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

7.4

32.6

A27

ICPC

Fear of other disease NOS

2.4

32.6

238

1033

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.5

32.6

1073

7475

G43.9

ICD-10 Finland

Migraine, unspecified

2.4

32.5

237

1028

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.7

32.5

692

4340

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

32.3

654

4046

OAB38, ,

SPAT

5.3

32.2

121

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

32.1

2447

20021

U07

ICPC

Urine symptom/complaint other

2.0

32.1

342

1729

ZYC02, ,

SPAT

4.2

32.0

209

K10.3

ICD-10 Finland

Alveolitis of jaws

2.5

31.9

214

894

ZXE21

NOMESCO Finland

Procedure duration at least 3 but less than 4 hours

8.8

31.9

ICC01

NOMESCO Finland

Psychiatric treatment plan, transfer to psychiatric outpatient clinic

88.1

31.7

ZXD05

NOMESCO Finland

Urgent procedure

1.5

31.7

1345

9872

R4120

NOMESCO Finland

Occupational therapy

2.1

31.6

308

1506

ZXY60

NOMESCO Finland

2-person team, nurses

36.6

31.5

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.9

31.3

151

535

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

31.1

1079

7591

ICB01, ,

SPAT

11.1

31.1

N05AX15

ATC

cariprazine; oral

60.4

31.1

J45

ICD-10 Finland

Asthma

1.8

31.0

472

2687

L13

ICPC

Hip symptom/complaint

1.6

31.0

854

5706

IGP01

NOMESCO Finland

Psychiatric family contact

11.5

30.9

Z50.7

ICD-10 Finland

Occupational therapy and vocational rehabilitation, not elsewhere classified

8.4

30.8

J45.1

ICD-10 Finland

Nonallergic asthma

2.0

30.8

334

1698

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

85.6

30.7

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.0

30.5

361

1893

XKC03

NOMESCO Finland

Water cystometry

2.9

30.5

146

515

F05.9

ICD-10 Finland

Delirium, unspecified

3.9

30.4

226

P98

ICPC

Psychosis NOS/other

8.2

30.3

M02AA10

ATC

ketoprofen; topical

1.6

30.2

754

4919

F34.0

ICD-10 Finland

Cyclothymia

58.7

30.1

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

4.2

30.1

193

A02BC04

ATC

rabeprazole; oral

1.9

30.0

410

2255

X15

ICPC

Vaginal symptom/complaint other

2.8

30.0

153

558

Z50.4

ICD-10 Finland

Psychotherapy, not elsewhere classified

32.7

29.9

S21

ICPC

Skin texture symptom/complaint

1.7

29.9

655

4131

IHZ01, ,

SPAT

8.1

29.8

N06AA21

ATC

maprotiline; systemic

304.1

29.8

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

29.8

1770

13809

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

28.8

29.8

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

29.6

597

3684

SPAT1312

SPAT

General health counselling

1.5

29.6

1395

10428

F20.39

ICD-10 Finland

Undifferentiated schizophrenia UNS

9.8

29.4

C10AC01

ATC

colestyramine; oral

3.0

29.1

133

457

J01CA08

ATC

pivmecillinam; oral

1.4

29.1

1856

14648

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.7

28.9

578

3558

C01CA01

ATC

etilefrine; systemic

6.6

28.9

C08CA01

ATC

amlodipine; oral

1.4

28.9

1741

13601

IHZ02, ,

SPAT

7.3

28.8

F13.3

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, withdrawal state

293.6

28.8

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.6

28.8

712

4630

EB1SA, ,

SPAT

2.2

28.7

262

1248

SPAT1139

SPAT

Nutrition survey

2.8

28.7

147

538

M03BX01

ATC

baclofen; systemic

3.8

28.6

227

L86

ICPC

Back syndrome with radiating pain

2.1

28.5

270

1305

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.7

28.5

532

3213

R51

ICD-10 Finland

Headache

2.2

28.5

240

1107

U05

ICPC

Urination problems other

2.3

28.5

226

1017

G47.1

ICD-10 Finland

Disorders of excessive somnolence [hypersomnias]

11.2

28.4

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

8.6

28.4

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.8

28.4

145

530

F34.9

ICD-10 Finland

Persistent mood [affective] disorder, unspecified

36.2

28.3

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

6.2

28.3

A03DA02

ATC

pitofenone and analgesics; systemic

3.3

28.3

106

324

A29

ICPC

General symptom/complaint other

1.7

28.1

538

3271

Z01.9

ICD-10 Finland

Special examination, unspecified

2.1

28.1

282

1394

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.8

28.0

458

2662

J01FF01

ATC

clindamycin; systemic

1.5

27.9

1239

9139

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.1

27.8

260

1251

WX780

NOMESCO Finland

Remote monitoring CPAP

2.3

27.8

207

907

IAB07

NOMESCO Finland

Consultation concerning a patient with self-harm intention

78.1

27.8

C10AA05

ATC

atorvastatin; oral

1.4

27.7

1932

15445

M01AH05

ATC

etoricoxib; oral

1.4

27.7

3014

25899

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.8

27.7

454

2641

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.8

27.6

142

521

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.8

27.5

432

2481

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.5

27.5

176

720

H01

ICPC

Ear pain/earache

1.7

27.5

487

2898

R55

ICD-10 Finland

Syncope and collapse

1.8

27.4

458

2679

F20.04

ICD-10 Finland

Paranoid schizophrenia with partial recurrence

9.2

27.4

ZXA00

NOMESCO Finland

Right side

1.5

27.2

1204

8870

ZYB04

NOMESCO Finland

Outreach service in patient’s home or everyday environment

30.2

27.2

F20.0

ICD-10 Finland

Paranoid schizophrenia

7.6

27.2

SPAT1284

SPAT

Extensive health certificate

3.1

27.1

111

358

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.4

27.1

195

842

F06.7

ICD-10 Finland

Mild cognitive disorder

3.0

27.0

122

417

R61.9

ICD-10 Finland

Hyperhidrosis, unspecified

4.5

26.8

146

A10BJ02

ATC

liraglutide; parenteral

2.8

26.8

135

490

SPAT1247

SPAT

Outpatient detoxication and monitoring

9.7

26.8

F25.11

ICD-10 Finland

Schizoaffective syndrome, depressive type with prolonged schizophrenic than bipolar symptoms

41.5

26.7

G21.1

ICD-10 Finland

Other drug-induced secondary parkinsonism

27.9

26.6

IBA02

NOMESCO Finland

Evaluation of need for psychiatric rehabilitation

24.8

26.5

F43.2

ICD-10 Finland

Adjustment disorders

3.9

26.5

203

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.9

26.4

379

2116

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

26.4

2825

24126

P19

ICPC

Drug abuse

7.9

26.4

D10AF01

ATC

clindamycin; topical

2.2

26.4

222

1024

F20

ICD-10 Finland

Schizophrenia

7.6

26.3

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.0

26.3

277

1394

M03BB52

ATC

chlormezanone, combinations excl. psycholeptics; oral, rectal

3.0

26.2

113

376

SPAT1058

SPAT

PEF monitoring instruction

1.9

26.2

361

1990

2961A

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,TARKEMMIN MÄÄRITTELEMÄTÖN]

36.9

26.1

Z3229

NOMESCO Finland

Other healthcare associate professional

1.9

26.1

362

2000

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.5

26.1

809

5536

K08.3

ICD-10 Finland

Retained dental root

1.9

26.0

335

1806

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.5

26.0

1120

8199

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

4.1

26.0

175

ZXY82

NOMESCO Finland

Nurse in multidisciplinary team

31.1

25.9

A11

ICPC

Chest pain NOS

1.9

25.9

364

2020

ZXY03

NOMESCO Finland

Occupational therapist

40.3

25.8

TKC20

NOMESCO Finland

Catheterisation of bladder

2.0

25.7

282

1440

3000A

ICD-9 Finland

Neurotic disorders, Anxiety states[TARKEMMIN MÄÄRITTELEMÄTÖN AHDISTUNEISUUSHÄIRIÖ]

21.9

25.6

E03

ICD-10 Finland

Other hypothyroidism

2.0

25.5

279

1422

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.8

25.5

129

469

U01

ICPC

Dysuria/painful urination

1.9

25.5

339

1848

C08DA01

ATC

verapamil; systemic

2.4

25.4

183

790

SPAT1389

SPAT

Visit based on need for special support

4.5

25.4

136

C07AB03

ATC

atenolol; systemic

2.1

25.4

253

1247

RS220, ,

NOMESCO Finland

4.2

25.4

161

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

25.4

909

6411

G01AF05

ATC

econazole; vaginal

1.8

25.2

364

2036

M03AX01

ATC

botulinum toxin; parenteral

4.6

25.2

133

L16

ICPC

Ankle symptom/complaint

1.7

25.1

496

3038

M01AX01

ATC

nabumetone; oral

2.3

25.1

196

877

F20.3

ICD-10 Finland

Undifferentiated schizophrenia

9.7

25.0

T42.4

ICD-10 Finland

Poisoning: Benzodiazepines

58.3

25.0

R5110, ,

SPAT

2.0

24.9

284

1470

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

24.8

519

3228

D19

ICPC

Teeth/gum symptom/complaint

1.4

24.8

1273

9615

L12

ICPC

Hand/finger symptom/complaint

1.6

24.8

699

4677

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.9

24.8

339

1865

S02

ICPC

Pruritus

2.5

24.7

154

622

N02BA71

ATC

acetylsalicylic acid, combinations with psycholeptics; systemic

2.9

24.7

113

389

F40.9

ICD-10 Finland

Phobic anxiety disorder, unspecified

21.3

24.7

R63.4

ICD-10 Finland

Abnormal weight loss

2.4

24.7

166

695

A02BB01

ATC

misoprostol; oral

6.8

24.6

R60.9

ICD-10 Finland

Oedema, unspecified

2.1

24.6

246

1214

WZA10, ,

SPAT

7.5

24.6

G04BD09

ATC

trospium; oral

3.0

24.6

109

369

J01MA12

ATC

levofloxacin; systemic

1.5

24.5

798

5511

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.7

24.5

436

2595

R32

ICD-10 Finland

Unspecified urinary incontinence

2.8

24.4

124

452

D07AD01

ATC

clobetasol; topical

1.5

24.4

776

5334

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

2.8

24.3

120

431

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

24.3

465

2824

W0A12

NOMESCO Finland

Planned therapy visit for psychiatric disease

22.0

24.3

ICB06, ,

NOMESCO Finland

48.6

24.3

Z73.0

ICD-10 Finland

Burn-out

2.6

24.2

136

522

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.2

24.2

218

1033

C09CA06

ATC

candesartan; oral

1.5

24.2

1082

7963

N02CC03

ATC

zolmitriptan; nasal, oral

2.1

24.1

230

1115

D01AC02

ATC

miconazole; topical

1.9

24.1

332

1830

N02BE51

ATC

paracetamol, combinations excl. psycholeptics; systemic

4.3

24.1

142

30300

ICD-8 Finland

Alcoholism, Episodic excessive drinking

6.2

24.1

R03AK07

ATC

formoterol and budesonide; inhalant

1.5

24.0

932

6672

N05AX16

ATC

brexpiprazole; oral

56.3

24.0

K04

ICPC

Palpitations/awareness of heart

2.1

24.0

241

1191

E23.04

ICD-10 Finland

Hypogonadotropic hypogonadism

5.1

24.0

K04.08

ICD-10 Finland

Other specified pulpit

1.9

23.9

311

1682

F60.1

ICD-10 Finland

Schizoid personality disorder

37.7

23.9

L05

ICPC

Flank/axilla symptom/complaint

2.0

23.9

272

1407

Z01.7

ICD-10 Finland

Laboratory examination

1.6

23.9

659

4386

S04

ICPC

Lump/swelling localized

1.7

23.9

456

2768

N04BB01

ATC

amantadine; oral

3.5

23.8

233

SPAT1051

SPAT

Guidance regarding sleep disorders

3.5

23.8

233

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

23.7

825

5774

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

7.0

23.7

G03FB05

ATC

norethisterone and estrogen; systemic

1.7

23.7

509

3188

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

23.6

676

4535

G04BD01

ATC

emepronium; systemic

5.8

23.6

D02

ICPC

Abdominal pain epigastric

2.0

23.6

270

1398

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

4.9

23.6

108

N07BB04

ATC

naltrexone; oral

41.6

23.6

A10BH01

ATC

sitagliptin; oral

1.8

23.5

407

2402

SPAT1237

SPAT

Psychotherapy

9.4

23.5

9691A

ICD-9 Finland

Poisoning by psychotropic agents, Phenothiazine-based tranquillisers

23.7

23.4

M01AC01

ATC

piroxicam; systemic, rectal

1.6

23.4

594

3875

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.2

23.4

202

942

WX002

NOMESCO Finland

Sedation and analgesia

1.5

23.4

853

6029

X11

ICPC

Menopausal symptom/complaint

3.7

23.4

203

ZXA05

NOMESCO Finland

Left side

1.4

23.3

1104

8204

R15

ICD-10 Finland

Faecal incontinence

2.7

23.3

125

469

R01AD12

ATC

fluticasone furoate; nasal

1.4

23.3

1390

10758

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

23.2

1138

8509

R03BC03

ATC

nedocromil; inhalant

1.9

23.2

315

1728

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

23.1

777

5400

V03AA02, ,

ATC

54.2

23.0

G50.1

ICD-10 Finland

Atypical facial pain

3.3

22.9

254

M54.8

ICD-10 Finland

Other dorsalgia

2.2

22.8

195

905

J02AC02

ATC

itraconazole; systemic

1.5

22.8

828

5842

D06

ICPC

Abdominal pain localized other

1.8

22.8

372

2159

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.0

22.8

256

1318

WX722

NOMESCO Finland

PEEP

2.2

22.8

200

939

E000006, ,

ATC

1.9

22.8

316

1746

A05

ICPC

Feeling ill

2.1

22.7

214

1032

X23

ICPC

Fear sexually transm dis female

2.5

22.7

138

551

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.6

22.7

536

3436

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.8

22.7

334

1880

N06AE02, ,

ATC

83.8

22.7

WYA10

NOMESCO Finland

Emergency care or similar visit

1.9

22.6

314

1734

F40.00

ICD-10 Finland

Agoraphobia without concomitant panic disorder

231.0

22.6

P17

ICPC

Tobacco abuse

3.9

22.6

171

X14

ICPC

Vaginal discharge

3.3

22.6

261

EB1AA, ,

SPAT

1.9

22.6

303

1656

SPAT1106

SPAT

Acupuncture

5.6

22.5

-50

ICPC

Medication/prescr/renewal

2.3

22.5

177

794

G72.8

ICD-10 Finland

Other specified myopathies

3.9

22.4

172

30320

ICD-8 Finland

Alcoholism, Alcoholic addiction

8.8

22.4

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

22.4

1140

8575

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.8

22.4

344

1961

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

22.4

548

3544

C01DA14

ATC

isosorbide mononitrate; oral

1.6

22.3

576

3772

R06AE09

ATC

levocetirizine; oral

1.6

22.3

631

4221

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.5

22.2

145

599

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.3

22.1

2207

18464

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.6

22.1

551

3579

L20

ICPC

Joint symptom/complaint NOS

2.3

22.1

169

750

WX110, ,

SPAT

2.0

22.1

261

1368

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.2

22.0

197

932

R00.2

ICD-10 Finland

Palpitations

1.8

21.9

334

1899

R5599

NOMESCO Finland

Other rehabilitation service

2.6

21.9

126

490

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.1

21.9

223

1108

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

2.1

21.8

209

1015

R01AD11

ATC

triamcinolone; nasal

1.7

21.8

388

2308

R03AC13

ATC

formoterol; inhalant

2.1

21.8

222

1103

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.1

21.8

223

1110

F60.0

ICD-10 Finland

Paranoid personality disorder

25.1

21.7

F25.1

ICD-10 Finland

Schizoaffective disorder, depressive type

38.8

21.7

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.7

21.7

416

2527

N76.0

ICD-10 Finland

Acute vaginitis

2.0

21.7

227

1140

SAA04

NOMESCO Finland

Special examination of mouth

2.0

21.6

231

1168

Z00.0

ICD-10 Finland

General medical examination

1.5

21.6

811

5756

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

3.0

21.6

326

G03FB06

ATC

medroxyprogesterone and estrogen; systemic

1.7

21.5

389

2325

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.7

21.5

456

2844

D82

ICPC

Teeth/gum disease

1.4

21.5

1634

13114

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.7

21.4

119

455

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.6

21.3

124

485

F50.8

ICD-10 Finland

Other eating disorders

26.5

21.3

R03AK03

ATC

[U] fenoterol and ipratropium bromide

2.1

21.3

195

931

M01AE01

ATC

ibuprofen; systemic, rectal

1.5

21.3

4556

42622

T74.1

ICD-10 Finland

Physical abuse

3.7

21.3

188

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.6

21.2

555

3643

H02AB04

ATC

methylprednisolone; systemic

1.5

21.2

630

4257

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.8

21.2

340

1964

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.2

21.1

182

848

A03CA05

ATC

glycopyrronium bromide and psycholeptics; systemic

3.8

21.1

166

SPAT1281

SPAT

Other administrative function

1.8

21.1

320

1817

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.5

21.1

792

5621

WX290, ,

SPAT

2.3

21.0

156

683

A08

ICPC

Swelling

2.0

21.0

222

1118

R4110, ,

SPAT

1.7

21.0

380

2272

K85

ICPC

Elevated blood pressure

1.5

20.9

705

4894

N02CC02

ATC

naratriptan; oral

3.1

20.9

279

F34.8

ICD-10 Finland

Other persistent mood [affective] disorders

60.3

20.9

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.9

20.8

250

1318

H02BX01

ATC

methylprednisolone, combinations; systemic

2.0

20.8

217

1089

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.6

20.7

568

3768

R33

ICD-10 Finland

Retention of urine

1.9

20.7

289

1599

U13

ICPC

Bladder symptom/complaint other

2.5

20.7

130

528

A13

ICPC

Concern/fear medical treatment

3.1

20.7

281

SPAT1262

SPAT

Handing over of treatment supplies

1.5

20.6

723

5061

IER03

NOMESCO Finland

Psychiatric disorder-specific group intervention

110.5

20.6

F03

ICD-10 Finland

Unspecified dementia

2.5

20.5

127

513

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.6

20.4

491

3159

F25.21

ICD-10 Finland

Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms

25.6

20.4

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

3.9

20.4

152

D09

ICPC

Nausea

2.2

20.4

166

756

R1250

NOMESCO Finland

Evaluation of functional capability

2.8

20.4

353

Z03

ICPC

Housing/neighbourhood problem

6.7

20.4

N06BA07

ATC

modafinil; oral

18.3

20.4

E9509

ICD-8 Finland

Suicide and self-inflicted poisoning by solid or liquid substances, Other and unspecified solid and liquid substances

5.6

20.4

N29

ICPC

Neurological sympt/complt other

3.1

20.4

268

E03.89

ICD-10 Finland

Other specified hypothyroidism

2.2

20.2

173

804

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

2.5

20.2

123

492

X58

ICD-10 Finland

Exposure to other specified factors

1.5

20.2

593

3996

SHA04

NOMESCO Finland

Stomatognathic treatment, very demanding

3.7

20.1

167

ZXY61

NOMESCO Finland

2-person team, special workers

48.2

20.1

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.1

20.1

197

965

Z63.7

ICD-10 Finland

Other stressful life events affecting family and household

4.0

20.1

145

SPAT1263

SPAT

Sampling

1.3

20.0

1800

14771

UJH02

NOMESCO Finland

Anoscopy

2.1

20.0

185

886

J31.0

ICD-10 Finland

Chronic rhinitis

1.7

20.0

362

2163

N05AA03

ATC

promazine; systemic

27.1

20.0

L04

ICPC

Chest symptom/complaint

1.9

20.0

267

1457

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.3

20.0

2163

18222

ZXD35

NOMESCO Finland

Usual procedure

2.4

19.9

143

617

F22.9

ICD-10 Finland

Persistent delusional disorder, unspecified

7.3

19.9

G47.0

ICD-10 Finland

Disorders of initiating and maintaining sleep [insomnias]

2.9

19.9

314

2961B

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,LIEVÄASTEINEN]

57.7

19.9

S10

ICPC

Boil/carbuncle

1.9

19.9

240

1267

K08.80

ICD-10 Finland

Toothache NOS

1.7

19.8

376

2275

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.6

19.8

112

432

G03FB08

ATC

dydrogesterone and estrogen; systemic

1.8

19.8

278

1541

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.7

19.8

344

2032

K07

ICPC

Swollen ankles/oedema

2.1

19.8

197

971

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.0

19.8

203

1012

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.2

19.8

170

792

D07AC13

ATC

mometasone; topical

1.4

19.7

1280

9996

R30.0

ICD-10 Finland

Dysuria

2.1

19.7

178

845

F84.5

ICD-10 Finland

Asperger syndrome

15.3

19.7

G04BD11

ATC

fesoterodine; oral

2.5

19.7

119

475

F23.3

ICD-10 Finland

Other acute predominantly delusional psychotic disorders

8.2

19.6

K03.00

ICD-10 Finland

Approximal wear

1.8

19.6

301

1715

D07CC01

ATC

betamethasone and antibiotics; topical

1.6

19.6

547

3642

N07AB01

ATC

carbachol; systemic

6.6

19.6

ZYD01

NOMESCO Finland

Emergency clinic

24.7

19.5

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.4

19.4

1190

9206

N02CX04, ,

ATC

2.8

19.4

357

-60

ICPC

Result test/procedure

1.9

19.4

253

1371

R06.4

ICD-10 Finland

Hyperventilation

3.5

19.3

191

N39.3

ICD-10 Finland

Stress incontinence

1.8

19.3

323

1888

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

6.3

19.3

D07XC01

ATC

betamethasone; topical

1.6

19.2

523

3461

A91

ICPC

Abnormal result investigation NOS

2.0

19.2

217

1119

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

19.2

1117

8566

N02CC04

ATC

rizatriptan; oral

2.0

19.2

219

1134

IEY03

NOMESCO Finland

Vocational rehabilitation

46.2

19.2

SGA03

NOMESCO Finland

Opening and preparing the root canals, complicated

1.6

19.1

414

2593

N30

ICD-10 Finland

Cystitis

1.7

19.1

328

1930

B18.2

ICD-10 Finland

Chronic viral hepatitis C

4.7

19.1

R01AX03

ATC

ipratropium bromide; nasal

2.7

19.1

104

394

F42.9

ICD-10 Finland

Obsessive-compulsive disorder, unspecified

26.1

19.1

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

26.1

19.1

N02AJ13

ATC

tramadol and paracetamol; systemic

2.7

19.1

366

30000

ICD-8 Finland

Neuroses, Anxiety neurosis

5.2

19.1

OAA80, ,

SPAT

0.4

19.1

108

2531

F50.2

ICD-10 Finland

Bulimia nervosa

20.1

19.0

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.8

19.0

268

1488

R03BA08

ATC

ciclesonide; inhalant

1.7

19.0

378

2317

E87.6

ICD-10 Finland

Hypokalaemia

2.3

19.0

140

612

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.9

19.0

230

1216

J05AB01

ATC

aciclovir; systemic

1.4

19.0

950

7102

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.6

18.9

413

2593

3041A

ICD-9 Finland

Drug dependence, Barbiturate and similarly acting sedative or hypnotic dependence

55.2

18.9

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.4

18.9

1112

8541

F50.3

ICD-10 Finland

Atypical bulimia nervosa

34.4

18.9

G03DB02

ATC

megestrol; oral

2.0

18.9

196

982

R03AC12

ATC

salmeterol; inhalant

2.1

18.8

182

888

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.2

18.7

159

737

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

18.7

757

5441

M54.2

ICD-10 Finland

Cervicalgia

1.7

18.7

332

1974

Z00.8

ICD-10 Finland

Other general examinations

1.7

18.6

317

1862

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.4

18.6

122

506

Z71.9

ICD-10 Finland

Counselling, unspecified

1.8

18.6

300

1735

R01AD58

ATC

fluticasone, combinations; nasal

1.4

18.6

1038

7901

IAB11

NOMESCO Finland

Psychiatric mood consultation

20.9

18.6

Z72.0

ICD-10 Finland

Tobacco use

2.6

18.6

108

423

R13

ICD-10 Finland

Dysphagia

1.8

18.6

274

1543

T43.0

ICD-10 Finland

Poisoning: Tricyclic and tetracyclic antidepressants

190.6

18.5

N06AC01, ,

ATC

190.6

18.5

SCA02

NOMESCO Finland

Preventive oral health care

1.7

18.5

391

2434

K58

ICD-10 Finland

Irritable bowel syndrome

2.5

18.5

118

483

R41.3

ICD-10 Finland

Other amnesia

2.5

18.5

117

477

L09

ICPC

Arm symptom/complaint

2.0

18.5

202

1031

I95.1

ICD-10 Finland

Orthostatic hypotension

2.3

18.4

133

576

G03DA02

ATC

medroxyprogesterone; systemic

1.6

18.4

399

2500

C05AA01

ATC

hydrocortisone; rectal, topical

1.9

18.3

230

1230

L60.0

ICD-10 Finland

Ingrowing nail

2.0

18.3

195

986

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.0

18.2

190

953

R45.8

ICD-10 Finland

Other symptoms and signs involving emotional state

7.5

18.2

W19

ICD-10 Finland

Unspecified fall

1.7

18.2

384

2390

IEY21

NOMESCO Finland

Other intensified psychiatric treatment

25.1

18.2

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

2.9

18.2

292

K11.71

ICD-10 Finland

Xerostomy (dry mouth)

4.0

18.1

129

G01AF01

ATC

metronidazole; vaginal

1.6

18.1

433

2781

ZXD20

NOMESCO Finland

Day surgery

1.5

18.1

549

3723

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.1

18.1

181

895

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3028707) Methadone [Presence] in Urine by Screen method

256

180

14.89

284.57

3.2

2.1

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

141

26.31

204.02

11.7

16.2

0.62

0.67

mmol/l

0.66

121

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1018

3990

2.92

182.88

2.1

1.5

1.51

1.40

5.98

875

3542

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2558

15679

2.21

170.71

2.2

1.9

97.54

96.23

pmol/l

0.69

1284

8004

(3009466) Valproate [Moles/volume] in Serum or Plasma

218

266

8.50

166.31

5.7

4.9

367.10

367.37

umol/l

0.01

186

234

(3011288) Drugs identified in Urine by Screen method

288

490

6.16

162.36

4.4

1.8

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4190

32024

2.44

154.09

5.0

3.8

14.53

14.86

pmol/l

15.95

3833

29174

(3015377) Calcium [Moles/volume] in Serum or Plasma

2203

13161

2.15

151.93

3.1

3.6

2.36

mmol/l

0.07

1920

11546

(3019309) Folate [Moles/volume] in Red Blood Cells

1298

6345

2.38

145.07

1.8

1.7

1211.00

1167.45

nmol/l

0.81

959

4811

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2513

16510

1.99

126.82

3.2

2.7

101.39

135.69

ug/l

17.13

2302

15422

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2669

17924

1.98

126.16

5.9

6.0

1.21

mmol/l

0.04

2440

16369

(3021960) Folate [Moles/volume] in Serum or Plasma

1521

8412

2.13

122.89

1.6

1.5

21.10

20.56

nmol/l

0.69

1298

7142

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2861

19840

1.95

121.30

6.1

6.8

1.21

mmol/l

0.04

2415

16895

(1001926) Buprenorphine [Presence] in Urine by Screen method

295

664

4.64

121.19

3.2

1.5

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4105

32351

2.17

120.31

7.9

7.5

77.57

77.68

u/l

0.05

3862

30589

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1312

6967

2.17

116.86

2.8

3.2

2.45

mmol/l

1.30

1118

6117

(3024561) Albumin [Mass/volume] in Serum or Plasma

2554

17200

1.93

116.56

4.3

5.0

36.03

35.61

g/l

3.50

2347

16028

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2473

16675

1.90

110.52

2.5

2.2

78.10

78.16

nmol/l

0.03

2210

15047

(3018418) pH of Serum or Plasma

1875

11650

1.94

106.45

3.9

4.2

7.40

0.37

327

2244

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

18.72

104.74

1.5

1.9

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4645

39228

2.42

103.56

6.3

4.4

1.79

2.13

mu/l

3.70

4329

35893

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1562

9192

1.99

103.41

2.4

2.2

2.81

2.95

mg/l

1.58

1325

7936

(3016879) Cocaine [Presence] in Urine

314

849

3.87

100.93

3.1

1.5

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1863

11893

1.87

94.85

2.3

2.0

204.68

208.61

u/l

0.07

1724

11135

(3027008) Opiates [Presence] in Urine

321

965

3.48

87.98

3.2

1.5

—

(3000764) Benzodiazepines [Presence] in Urine

319

956

3.49

87.86

3.3

1.5

—

(3028300) Cannabinoids [Presence] in Urine

321

967

3.47

87.70

3.3

1.4

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2880

21285

1.77

87.55

5.9

6.3

10.13

11.50

umol/l

10.17

2708

20292

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1421

8502

1.92

87.04

1.3

1.2

1.31

1.73

u/ml

0.82

365

2315

(3013707) Erythrocyte sedimentation rate by Westergren method

3863

31165

1.87

86.97

4.3

4.0

12.02

12.19

mm/h

0.31

3586

28960

(3031040) Bacteria [#/volume] in Urine by Automated count

3438

26802

1.80

86.35

5.3

3.9

155.34

1182.78

e6/l

2.44

343

(3013650) Neutrophils [#/volume] in Blood by Automated count

3155

23992

1.77

86.30

10.0

9.1

4.13

4.02

e9/l

1.84

2694

20940

(3036481) Cortisol [Moles/volume] in Serum or Plasma

691

3182

2.35

84.57

2.2

2.4

351.78

379.82

nmol/l

3.48

637

2954

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1963

13247

1.76

79.76

3.4

3.2

38.48

35.19

u/l

0.16

1837

12595

(3027944) Amphetamines [Presence] in Urine

307

961

3.33

78.82

3.1

1.5

—

(3019198) Lymphocytes [#/volume] in Blood

2826

21177

1.71

78.05

6.2

5.9

1.96

1.92

e9/l

0.38

2440

18763

(3013115) Eosinophils [#/volume] in Blood

2841

21325

1.71

77.94

6.6

6.0

0.19

e9/l

0.40

2435

18744

(3001604) Monocytes [#/volume] in Blood

2761

20566

1.71

77.91

6.2

5.8

0.58

e9/l

0.53

2310

17820

(3006315) Basophils [#/volume] in Blood

2765

20617

1.71

77.61

6.1

5.8

0.04

e9/l

0.57

2310

17845

(3018095) Leukocytes [#/volume] in Urine

2051

14147

1.73

76.21

4.1

3.5

89.82

98.16

e6/l

0.10

1424

9908

(3044889) 12 lead EKG panel

3703

30071

1.76

74.60

4.3

3.6

—

(40760892) CBC W Ordered Manual Differential panel - Blood

2609

19312

1.69

73.89

6.3

6.5

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1246

7536

1.85

71.70

1.5

2.38

2.44

g/l

0.44

693

4675

(36304419) Bacteria [Presence] in Urine

1623

10677

1.75

70.09

3.5

2.9

—

(3015736) pH of Urine

2220

15979

1.67

68.16

3.7

3.1

5.86

5.82

0.16

122

1296

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3477

28123

1.68

67.01

3.9

2.8

53.16

46.08

u/l

3.16

3204

26317

(3030467) Casts [#/volume] in Urine by Automated count

1645

10972

1.72

67.00

3.6

3.0

0.39

e6/l

0.06

1254

8255

(3033658) Prothrombin time (PT) actual/Normal

1596

10571

1.73

66.59

4.3

3.8

92.58

90.54

2.59

1556

10335

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1803

12358

1.69

66.23

2.7

2.5

58.12

66.16

u/l

0.63

1639

11486

(40758558) Short blood count panel - Blood

1572

10390

1.73

65.98

7.9

6.9

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

3063

24046

1.64

65.76

4.9

4.4

6.60

6.69

mmol/l

1.55

2865

22440

(3037467) Urinalysis macro (dipstick) panel - Urine

3506

28499

1.67

65.47

4.9

4.0

—

(3048689) Calprotectin [Mass/mass] in Stool

846

4653

1.97

64.30

2.2

2.3

121.04

145.23

ug/g

0.92

657

3748

(3009508) Creatinine [Moles/volume] in Urine

1836

12745

1.67

63.68

3.4

3.2

7.44

7.51

mmol/l

0.22

1529

10800

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1274

8003

1.78

63.57

1.8

1.6

44946478.09

37465050.40

pmol/l

0.13

1019

6713

(44816559) Phosphatidylethanol [Mass/volume] in Blood

191

512

3.83

61.94

1.3

—

(3036180) Methadone [Presence] in Urine

10.76

61.89

3.3

1.6

—

(3002582) Erythrocytes [#/volume] in Urine

1735

12019

1.66

59.80

3.6

3.0

38.81

89.35

e6/l

2.04

1327

9137

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

587

2909

2.14

59.00

2.1

1.8

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

688

3665

2.01

56.81

2.5

2.4

38.16

36.61

u/l

0.12

578

3163

(3022096) Basophils/100 leukocytes in Blood

2459

18753

1.58

55.82

6.2

6.1

0.70

0.69

0.49

2257

17543

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

626

3258

2.04

55.05

2.2

1.8

—

(3019069) Monocytes/100 leukocytes in Blood

2531

19477

1.57

54.91

6.4

8.58

8.63

0.34

2334

18298

(3021589) Normoblasts [#/volume] in Blood

2430

18535

1.57

54.75

10.0

9.2

0.00

e9/l

0.05

1912

15222

(3006504) Eosinophils/100 leukocytes in Blood

2519

19372

1.57

54.75

6.1

2.87

2.86

0.12

2326

18157

(3002030) Lymphocytes/100 leukocytes in Blood

2586

20043

1.56

54.04

6.2

6.1

28.16

28.07

0.16

2396

18858

(3000850) Epithelial cells [#/volume] in Urine

1253

8151

1.70

53.89

2.8

2.5

5.63

5.39

e6/l

0.23

1117

7339

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

20.14

52.09

2.4

2.9

17.79

18.91

umol/l

0.16

(3018010) Neutrophils/100 leukocytes in Blood

2543

19774

1.55

51.41

6.0

5.9

57.01

57.09

0.13

2350

18593

(40768797) Stomach Pathology biopsy report

916

5533

1.79

50.89

1.3

1.2

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

4894

44777

2.12

50.47

19.5

14.3

139.52

139.78

mmol/l

10.96

4794

43659

(3011397) Hemoglobin [Presence] in Urine by Test strip

1384

9402

1.64

49.74

4.0

3.4

—

(3026782) Osmolality of Urine

1181

7703

1.68

49.73

3.0

2.9

518.50

546.91

mosm/kgh2o

4.21

997

6643

(3021601) Nitrite [Presence] in Urine by Test strip

2578

20240

1.53

48.97

5.3

4.6

0.00

estimate

-0.00

503

3652

(3017446) Testosterone [Moles/volume] in Serum or Plasma

522

2669

2.06

47.89

2.7

2.0

12.66

12.76

nmol/l

0.09

457

2403

(3035350) Ketones [Presence] in Urine by Test strip

2562

20188

1.52

47.16

4.1

3.4

0.00

estimate

0.11

516

3898

(3023103) Potassium [Moles/volume] in Serum or Plasma

4891

44954

2.06

46.39

19.5

14.5

3.95

3.97

mmol/l

2.64

4779

43735

(3009261) Glucose [Presence] in Urine by Test strip

2586

20470

1.51

46.23

4.1

3.4

0.01

0.00

estimate

0.25

487

3559

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4472

39991

1.73

46.22

6.7

5.3

39.69

39.58

mmol/mol

0.35

4155

37106

(3026008) Bacteria identified in Urine by Culture

1645

11827

1.57

45.86

3.6

2.8

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4751

43349

1.88

44.47

16.5

12.6

22.58

23.64

mg/l

1.31

3803

33686

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

474

2403

2.07

44.39

2.9

3.6

4.41

4.51

pmol/l

1.09

403

2166

(3012095) Magnesium [Moles/volume] in Serum or Plasma

995

6385

1.69

43.89

2.8

3.4

0.82

mmol/l

0.12

914

6009

(1002224) Polysomnography panel

346

1573

2.28

42.65

1.1

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

8.51

42.06

2.2

2.7

121.24

148.13

nmol/l

1.01

(3014111) Lactate [Moles/volume] in Serum or Plasma

581

3233

1.89

41.50

6.9

7.2

1.31

mmol/l

0.05

565

3163

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1028

6744

1.65

41.38

3.0

2.6

1.12

1.18

e6/l

0.15

565

3813

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1538

11156

1.53

40.07

3.1

2.9

922.66

1365.79

ng/l

6.44

1273

9632

(3022948) Iron [Moles/volume] in Serum or Plasma

917

5927

1.66

38.87

2.3

2.6

12.91

13.11

umol/l

0.34

840

5590

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

958

6299

1.63

37.85

3.1

2.8

3.28

2.68

e6/l

0.76

494

3389

(3004789) Transferrin [Mass/volume] in Serum or Plasma

853

5459

1.67

37.44

2.3

2.6

2.38

2.32

g/l

2.30

757

5117

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

244

1008

2.49

37.27

1.2

1.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4640

42485

1.71

36.96

5.4

4.3

6.00

5.89

mmol/l

6.91

4253

38935

(3000991) Gas panel - Venous blood

546

3097

1.85

36.53

7.9

8.6

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

242

1007

2.47

36.40

1.8

1.7

339.08

295.00

mu/l

1.19

219

926

(3014765) Yersinia sp identified in Stool by Organism specific culture

243

1018

2.45

36.02

1.2

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

244

1025

2.45

35.95

1.2

1.1

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1959

15186

1.46

35.82

3.9

3.2

30.51

44.96

ng/l

2.23

1288

10124

(3012516) Albumin [Mass/volume] in Urine

1633

12242

1.48

35.36

3.3

251.87

407.78

mg/l

0.87

1022

7631

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

4544

41493

1.64

35.20

15.5

12.1

82.25

81.01

ml/min/173m2

3.78

3801

34234

(3022217) INR in Platelet poor plasma by Coagulation assay

2341

18813

1.44

35.04

13.7

14.3

1.20

1.26

inr

2.63

682

5382

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1039

7087

1.58

34.92

1.3

64.09

35.26

iu/ml

0.37

277

2390

(4200892) Spirometry reversibility

499

2805

1.86

34.27

1.5

1.4

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1541

11485

1.48

34.11

1.6

1.49

1.33

mmol/l

8.90

1247

9676

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

177

654

2.76

33.88

2.1

1.8

205.41

207.03

pmol/l

0.06

165

625

(3003458) Phosphate [Moles/volume] in Serum or Plasma

781

5008

1.66

33.73

4.4

6.3

1.02

1.03

mmol/l

0.51

710

4699

(3019150) Specific gravity of Urine by Refractometry

1201

8520

1.53

33.70

4.6

3.7

1.02

kg/l

0.15

148

1296

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1108

7741

1.54

33.30

3.8

3.5

146.56

622.73

ng/l

3.32

824

5997

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

228

963

2.43

33.20

2.0

1.7

40.70

42.64

nmol/l

0.61

222

934

(3022145) Colonoscopy Study observation

737

4679

1.67

33.04

1.3

1.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

267

1213

2.26

32.89

1.6

1.7

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1687

12881

1.45

32.64

3.8

8.15

8.91

mg/mmol

0.24

1010

8024

(3023368) Bacteria identified in Blood by Culture

1400

10310

1.49

32.63

4.5

4.1

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1236

8878

1.51

32.53

1.9

1.7

1.03

1.22

mg/l

1.84

926

6861

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

725

4627

1.66

31.76

2.5

2.8

7.16

8.46

umol/l

0.97

600

4066

(3029937) Albumin [Presence] in Urine by Test strip

1431

10661

1.47

31.20

4.8

3.8

0.00

estimate

1.98

488

3528

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

460

2617

1.83

30.29

1.5

1.6

—

(3025941) Bacteria identified in Stool by Culture

386

2077

1.93

30.24

1.3

1.2

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

780

5148

1.60

29.70

2.4

2.6

21.96

22.88

1.12

674

4448

(3002385) Erythrocyte distribution width [Ratio]

4162

37671

1.48

29.27

20.3

15.2

14.82

15.05

0.90

4081

36999

(36660697) Celiac disease serology panel - Serum

508

3016

1.76

28.93

1.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

230

1048

2.25

28.14

1.4

291.06

270.65

ug/g

0.26

129

620

(3037522) Nuclear Ab [Titer] in Serum

814

5519

1.56

27.44

1.4

1.3

485.99

578.90

titre

0.68

147

1215

(3014576) Chloride [Moles/volume] in Serum or Plasma

733

4854

1.59

27.36

7.6

7.1

104.04

104.54

mmol/l

1.94

733

4848

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

958

6745

1.51

27.12

1.3

1.2

6.18

13.58

u/ml

4.47

333

2710

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

636

4078

1.64

27.10

1.9

1.7

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

869

5999

1.54

26.96

1.9

1.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

629

4069

1.62

25.79

1.9

1.6

—

(3024354) Oxygen [Partial pressure] in Venous blood

452

2684

1.75

25.64

3.6

3.1

4.64

4.56

kpa

0.36

438

2603

(3002032) Base excess in Venous blood by calculation

534

3323

1.67

25.51

3.8

2.08

1.86

mmol/l

0.67

480

2830

(3000494) Fungus identified in Specimen by Culture

721

4830

1.57

25.49

1.5

1.4

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

533

3335

1.66

24.91

3.8

5.94

5.81

kpa

2.30

523

3243

(46235355) HIV 1 and 2 tests - Meaningful Use set

884

6225

1.50

24.79

1.9

1.7

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

880

6214

1.50

24.30

1.9

2.1

29.72

29.84

0.26

857

6045

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

658

4366

1.58

24.17

7.1

7.4

5.24

5.07

kpa

5.19

636

4157

(40761535) Cells panel - Urine sediment

507

3161

1.67

23.99

3.9

3.4

—

(3003396) Base excess in Arterial blood by calculation

657

4365

1.58

23.99

7.1

7.4

1.19

1.01

mmol/l

0.58

570

3428

(3027801) Oxygen [Partial pressure] in Arterial blood

657

4365

1.58

23.99

7.1

7.4

11.48

12.83

kpa

11.12

633

4153

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

5.32

23.68

2.2

2.5

139.08

158.84

umol/l

0.12

(3009214) Lutropin [Units/volume] in Serum or Plasma

194

887

2.23

23.56

1.4

1.3

8.60

11.49

u/l

2.44

153

728

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

103

346

3.02

23.55

1.6

1.4

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

568

3668

1.61

23.35

2.2

2.3

0.22

0.21

g/l

0.77

522

3455

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4943

46948

1.72

23.28

12.5

9.8

26.67

26.20

u/l

1.09

4793

45320

(3052851) Hemolysis interference index of Serum or Plasma

235

1165

2.06

23.21

2.5

3.0

—

(3007853) Bacteria identified in Skin by Aerobe culture

664

4460

1.56

23.06

1.9

1.7

—

(3042936) Bacteria identified in Isolate by Culture

805

5641

1.50

22.97

1.9

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

339

1915

1.82

22.74

1.1

1.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

316

1755

1.85

22.39

2.3

1.7

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

336

2.98

22.25

1.4

1.8

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

158

680

2.36

22.13

1.4

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

158

680

2.36

22.13

1.4

1.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

646

4376

1.54

21.52

1.6

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

260

1380

1.93

21.18

2.3

1.7

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

716

5002

1.50

20.57

8.1

6.1

—

(3014007) Fractional oxyhemoglobin in Arterial blood

398

2431

1.69

20.29

9.3

9.2

92.62

94.33

3.86

398

2423

(3027945) Reticulocytes/100 erythrocytes in Blood

615

4180

1.53

20.11

2.1

2.6

1.84

1.78

0.65

531

3737

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

178

841

2.16

19.97

1.2

1.3

417.20

539.50

mg/l

7.14

171

808

(3020564) Creatinine [Moles/volume] in Serum or Plasma

4915

46852

1.62

19.77

19.4

14.9

75.98

76.44

umol/l

0.54

4915

46834

(3013139) Helicobacter pylori Ag [Presence] in Stool

439

2770

1.64

19.73

1.2

1.3

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3031

26761

1.31

19.66

3.1

2.7

—

(3016502) Oxygen saturation in Arterial blood

578

3902

1.54

19.47

7.5

7.8

94.70

96.00

3.43

566

3734

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

392

2411

1.68

19.46

9.3

9.2

0.68

0.67

0.18

392

2387

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1881

15585

1.32

19.41

4.5

3.5

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

295

1680

1.80

19.26

1.4

1.3

26.37

33.27

iu/l

3.19

246

1469

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

502

3292

1.58

19.22

2.5

2.2

5.57

8.24

ug/l

3.78

423

2952

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

392

2420

1.67

19.18

9.3

9.1

1.40

1.29

1.47

392

2399

(3026493) Urate [Moles/volume] in Serum or Plasma

1399

11149

1.35

18.76

2.5

2.6

4727.88

4896.35

umol/l

0.05

1175

9868

(40768804) Tissue Pathology biopsy report

2119

17910

1.30

18.71

2.2

2.1

—

(3023183) Ammonium ion [Moles/volume] in Plasma

147

672

2.22

17.94

2.7

2.8

39.72

33.68

umol/l

0.50

134

614

(3015171) Extractable nuclear Ab [Units/volume] in Serum

271

1540

1.80

17.83

1.2

1.3

0.19

1.21

u/ml

2.68

157

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

156

736

2.15

17.61

1.2

1.3

12.84

28.56

e6/l

0.99

118

568

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

156

736

2.15

17.61

1.2

1.4

992.34

672.16

e6/l

0.19

124

603

(40761511) CBC panel - Blood by Automated count

4800

45684

1.51

17.47

15.1

11.8

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

534

3640

1.52

17.12

7.8

8.2

121.89

121.16

g/l

0.36

528

3532

(3003181) Sodium [Moles/volume] in Urine

129

574

2.28

16.82

1.4

1.3

58.31

64.68

mmol/l

0.95

472

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

340

2099

1.66

16.62

3.3

3.4

1.75

1.81

mmol/l

0.11

254

1547

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

354

2220

1.64

16.27

3.4

5.21

5.11

kpa

1.44

335

2114

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

219

1208

1.85

15.89

1.3

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

225

1252

1.83

15.88

2.0

2.3

552.87

716.97

ug/l

0.31

210

1176

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

450

3010

1.54

15.72

3.4

4.1

85.34

93.56

ng/l

1.21

374

2594

(3009343) pH of Capillary blood

347

2187

1.63

15.63

3.4

7.42

0.33

270

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

+∞

15.63

1.5

0.0

554.36

—

nmol/l

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

151

742

2.07

15.37

1.1

1.3

3.79

3.78

mmol/l

0.04

144

698

(3019060) Gas panel - Arterial blood

379

2453

1.59

15.30

4.7

5.0

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

185

3.21

15.28

1.1

1.0

333.20

362.01

ng/l

0.26

139

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

185

3.21

15.28

1.1

1.0

804.87

730.48

ng/l

0.46

138

(3004716) Salmonella sp identified in Stool by Organism specific culture

307

1896

1.66

14.99

1.2

1.4

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

425

2838

1.54

14.95

2.3

2.4

25.09

23.08

au/ml

0.09

240

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

188

3.16

14.89

1.1

1.0

38.97

46.36

ng/l

0.57

139

(3023410) Appearance of Cerebral spinal fluid

338

2.57

14.77

1.3

1.5

—

(3024928) Oxygen saturation in Venous blood

153

767

2.02

14.76

3.8

3.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

396

2614

1.56

14.67

1.2

96.29

155.57

iu/ml

2.60

114

1027

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

914

7053

1.36

14.67

1.5

1.4

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4704

44832

1.42

14.64

5.6

4.7

2.71

2.82

mmol/l

15.13

4322

41556

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

325

2061

1.61

14.29

1.6

1.4

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

338

2164

1.60

14.28

1.7

1.6

—

(3020891) Body temperature

247

1460

1.73

14.22

6.6

4.5

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

210

2.98

14.12

1.4

1.2

1.61

1.17

promille

1.28

167

(3044640) Blood type and Crossmatch panel - Blood

1589

13298

1.28

14.07

2.3

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

270

1658

1.66

13.50

4.0

2.7

0.63

0.64

0.27

270

1647

(3008295) Osmolality of Serum or Plasma

321

2.51

13.21

1.6

1.3

280.63

278.25

mosm/kgh2o

0.36

259

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

315

2021

1.59

13.20

8.9

9.5

24.45

24.33

mmol/l

0.26

300

1976

(3016018) Differential panel - Cerebral spinal fluid

382

2.38

13.16

1.3

—

(3044290) Cell count panel - Cerebral spinal fluid

140

710

2.00

13.12

1.2

1.3

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

465

3259

1.47

12.93

4.0

3.8

1.23

mmol/l

0.08

390

2894

(3043409) Potassium [Moles/volume] in Arterial blood

195

1111

1.78

12.79

5.9

4.2

3.84

3.90

mmol/l

1.24

195

1095

(3005322) IgE [Units/volume] in Serum or Plasma

360

2403

1.53

12.68

1.3

184.30

234.55

u/ml

0.70

324

2229

(21494755) Public health laboratory ask at order entry panel

295

4486

0.64

12.55

1.3

1.4

—

(1616796) Gas panel - Central venous blood

153

813

1.91

12.54

4.4

3.5

—

(3020961) Endomysium IgA Ab [Titer] in Serum

282

1789

1.61

12.40

1.1

139.00

253.62

titre

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

381

2587

1.51

12.39

1.3

59.84

56.50

au/ml

0.10

168

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

179

1009

1.80

12.18

1.8

2.4

0.00

g/l

-0.00

160

941

(3020779) Urea [Moles/volume] in Serum or Plasma

486

3474

1.44

12.17

5.8

8.0

8.87

9.87

mmol/l

2.68

458

3329

(3023520) Reticulocytes [#/volume] in Blood

442

3110

1.46

12.03

2.3

2.7

74.18

68.89

e9/l

1.62

329

2374

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

180

1024

1.78

11.89

1.8

2.4

0.00

g/l

-0.00

160

944

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1227

10122

1.28

11.85

2.2

2.3

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4446

42294

1.31

11.61

4.3

3.8

1.41

1.27

mmol/l

26.49

4024

38908

(3011985) Renin [Units/volume] in Plasma

112

552

2.05

11.41

1.5

1.4

64.39

59.95

mu/l

0.08

497

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4611

44109

1.33

11.40

4.9

4.3

4.60

4.75

mmol/l

18.35

4239

41088

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

708

5449

1.35

11.36

1.5

1.6

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

189

1113

1.72

11.09

1.8

2.4

0.00

0.02

g/l

0.86

169

1029

(3005719) IgG [Mass/volume] in Serum or Plasma

432

3079

1.44

10.98

2.3

2.8

10.57

10.70

g/l

0.25

380

2834

(3021879) Hepatitis B virus core Ab [Presence] in Serum

418

2961

1.45

10.98

1.4

—

(3004588) Protein electrophoresis panel - Serum or Plasma

382

2668

1.47

10.81

1.9

2.4

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

309

2070

1.52

10.73

2.2

2.4

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4580

43844

1.32

10.69

4.9

4.2

1.43

1.50

mmol/l

23.57

4190

40661

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

546

4082

1.38

10.53

3.9

3.1

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

155

886

1.77

10.13

3.1

3.0

24.88

24.71

mmol/l

0.19

150

875

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

106

537

1.99

10.06

1.4

1.3

25.18

31.98

u/l

1.24

432

(40761536) Microorganisms panel - Urine sediment

457

3344

1.40

10.02

4.8

3.7

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

104

526

2.00

9.93

1.4

1.3

405.53

294.09

pmol/l

0.92

455

(3020630) Protein [Mass/volume] in Serum or Plasma

447

3265

1.40

9.90

2.0

2.8

66.44

66.60

g/l

0.17

393

2985

(3049717) Cytology report of Urine Cyto stain

224

1423

1.60

9.85

2.5

2.7

—

(3007566) Smooth muscle Ab [Titer] in Serum

185

1122

1.67

9.78

1.3

83.75

166.63

titre

0.85

104

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

9.53

9.74

8.9

13.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

476

2.04

9.69

1.3

1.6

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

228

2.52

9.58

1.1

1.17

13.15

nmol/l

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

202

1266

1.62

9.40

2.0

2.5

0.61

1.02

g/l

1.03

173

1096

(3000492) Spirometry study

545

4145

1.35

9.40

1.4

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

142

813

1.77

9.26

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

186

1148

1.64

9.21

1.8

2.3

38.18

37.77

g/l

0.41

165

1009

(3023511) Choriogonadotropin [Units/volume] in Urine

452

2.03

9.16

1.4

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

144

832

1.75

9.11

1.2

1.3

28.97

47.78

u/ml

0.89

(3021901) Oxygen saturation in Capillary blood

117

635

1.86

9.10

3.1

2.7

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

116

3.12

9.04

1.9

2.9

26.46

29.95

umol/l

0.87

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

224

2.47

8.93

1.6

1.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

144

838

1.74

8.89

2.6

2.1

130.41

129.03

g/l

0.28

100

587

(3008152) Bicarbonate [Moles/volume] in Arterial blood

334

2362

1.44

8.88

8.1

7.1

25.38

24.46

mmol/l

5.53

329

2225

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

116

636

1.84

8.75

1.9

1.6

—

(3028026) IgM [Mass/volume] in Serum or Plasma

337

2394

1.44

8.74

1.7

1.8

1.10

1.36

g/l

3.28

297

2192

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

590

4590

1.32

8.71

1.6

—

(3000475) Leukocytes [#/volume] in Synovial fluid

160

966

1.68

8.65

1.5

1.6

15106.58

11754.85

e6/l

0.27

108

702

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

454

3404

1.36

8.58

2.7

2.5

67.27

66.06

ml/min/173m2

0.26

200

1305

(3002256) Pathology report gross observation

718

5751

1.29

8.53

1.2

1.3

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

320

2.17

8.34

1.2

67.50

185.00

titre

1.88

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

182

1147

1.61

8.33

1.3

10.47

47.64

u/ml

3.78

(3010421) pH of Blood

159

972

1.66

8.22

4.5

3.9

7.41

7.42

1.84

144

900

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

222

1474

1.53

8.10

1.6

1.7

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

208

1368

1.54

7.93

3.5

3.7

24.92

24.86

mmol/l

0.12

193

1252

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

212

1402

1.53

7.89

1.9

2.5

2.83

2.93

g/l

0.92

190

1264

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

208

1376

1.53

7.74

1.6

229.29

365.67

titre

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

163

1019

1.62

7.73

1.2

1.3

—

(3022313) Gas panel - Capillary blood

234

1593

1.49

7.60

3.3

3.5

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

573

4529

1.30

7.52

3.9

4.8

235.01

244.76

u/l

0.92

543

4311

(40767503) Oxygen content in Capillary blood by calculation

131

780

1.70

7.52

3.3

2.4

16.49

16.23

0.31

387

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

309

4227

0.71

7.50

1.7

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

119

2.87

7.46

1.1

1.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

214

1440

1.51

7.37

1.7

2.90

4.02

mg/l

1.26

173

992

(3013512) EKG study

1394

12167

1.20

7.36

3.8

3.7

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

497

1.87

7.34

1.3

1.4

0.40

0.38

nmol/l

0.04

384

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

118

688

1.73

7.31

1.2

1.3

—

(3007463) Buprenorphine [Presence] in Urine

+∞

7.29

16.6

0.0

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

4.48

7.17

1.2

1.1

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

207

1393

1.51

7.13

1.9

2.5

10.12

10.26

g/l

0.16

184

1244

(3012501) Base excess in Blood by calculation

137

840

1.65

7.06

4.8

3.8

2.96

2.49

mmol/l

0.75

581

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

106

606

1.76

7.05

1.4

1.3

0.64

2.49

nmol/l

0.49

101

586

(3035320) C reactive protein [Mass/volume] in Body fluid

276

2.15

7.04

3.3

2.2

—

(3025130) Human papilloma virus identified in Specimen

533

1.82

7.04

1.5

1.7

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

154

973

1.60

7.03

1.2

1.1

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

106

608

1.76

6.98

1.4

1.3

0.14

0.28

nmol/l

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2192

19949

1.17

6.92

2.5

—

(3039443) Prostate specific Ag panel - Serum or Plasma

849

0.41

6.91

1.5

1.6

—

(3026389) Candida sp identified in Specimen by Organism specific culture

523

1.81

6.86

1.4

—

(1761868) Lipid panel - Serum or Plasma

1445

16295

0.84

6.77

3.0

2.7

—

(3006653) Thiamine [Moles/volume] in Blood

155

2.53

6.75

1.2

149.90

133.28

nmol/l

0.83

155

(3021788) Differential panel - Synovial fluid

121

729

1.68

6.69

1.4

1.5

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

3.39

6.68

1.2

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

337

2.00

6.63

1.3

1.5

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

246

1740

1.43

6.60

2.0

1.9

38.77

39.67

u/l

0.29

213

1533

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

217

1500

1.47

6.58

1.9

2.5

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

217

1500

1.47

6.58

1.9

2.5

7.19

7.41

g/l

1.39

196

1361

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

546

1.77

6.53

1.4

1.3

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

3.07

6.45

1.2

79.63

111.03

nmol/l

0.89

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

832

6990

1.23

6.44

1.5

1.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

5020

49158

1.36

6.43

26.2

18.5

40.26

40.60

1.14

4756

46010

(43055514) Macroprolactin [Presence] in Serum or Plasma

3.51

6.42

1.3

1.6

—

(3016038) Potassium [Moles/volume] in Urine

215

2.24

6.40

1.1

31.70

35.31

mmol/l

0.56

188

(3008402) Methanol [Moles/volume] in Serum or Plasma

6.54

6.32

1.0

—

mmol/l

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

6.54

6.32

1.0

1.1

—

mmol/l

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

215

1499

1.45

6.25

1.9

2.5

3.83

3.67

g/l

0.95

194

1361

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

7.01

6.21

1.0

1.5

—

37.86

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

421

3284

1.31

6.11

2.5

2.8

149.48

181.90

ng/l

1.10

384

2991

(3007461) Platelets [#/volume] in Blood

5021

49202

1.35

6.10

26.0

18.5

254.41

251.66

e9/l

2.31

4902

47906

(3044941) Cell count panel - Synovial fluid

104

618

1.70

6.09

1.5

1.4

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

182

1235

1.49

6.08

1.7

1.8

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

104

619

1.69

6.06

1.1

—

(3010813) Leukocytes [#/volume] in Blood

5024

49243

1.35

6.03

26.0

18.5

6.74

6.60

e9/l

3.54

4891

47803

(3035941) MCH [Entitic mass]

5023

49236

1.35

5.99

25.8

18.4

30.39

30.31

2.54

4954

48551

(3024731) MCV [Entitic volume]

5023

49239

1.34

5.96

25.9

18.4

91.29

91.00

4.50

4955

48557

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

451

1.81

5.95

1.0

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

155

1023

1.53

5.92

1.1

1.00

9.01

u/ml

2.74

122

(3026361) Erythrocytes [#/volume] in Blood

5023

49247

1.34

5.88

26.0

18.4

4.47

4.51

e12/l

8.36

4883

47823

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

179

2.30

5.84

1.4

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

573

1.71

5.82

1.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

462

1.79

5.80

1.2

55.89

63.04

u/l

0.53

417

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

265

2.05

5.77

1.2

29.83

18.96

u/l

0.48

226

(3000963) Hemoglobin [Mass/volume] in Blood

5023

49260

1.34

5.76

26.1

18.5

134.87

135.96

g/l

6.32

4957

48577

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

160

1072

1.51

5.71

1.3

4.96

6.49

u/ml

0.29

160

(3041096) Erythrocytes [Presence] in Urine by Automated

1245

10966

1.18

5.70

3.7

3.1

—

(3023419) Bacteria identified in Sputum by Culture

547

1.71

5.68

2.3

2.6

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

103

2.73

5.68

1.3

1.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

3.11

5.60

1.9

1.4

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

536

1.71

5.54

1.5

1.3

—

nmol/l

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

157

1059

1.50

5.44

1.3

11.82

5.63

u/ml

0.24

104

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

273

1.99

5.34

1.2

89.80

85.12

u/l

0.19

242

(3024980) IgG subclass 4 [Mass/volume] in Serum

108

675

1.61

5.26

1.4

1.6

0.71

0.83

g/l

0.56

509

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

342

1.85

5.08

1.1

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

13.35

5.07

1.1

1.0

16.31

7.65

nmol/l

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

191

2.16

5.05

1.0

1.1

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

177

1242

1.44

5.05

1.6

1.20

1.18

g/l

0.39

172

1177

(3017569) Oxygen content in Arterial blood

154

2.28

4.94

1.8

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

131

871

1.52

4.90

1.3

2.50

3.66

u/ml

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

4.56

4.85

1.2

—

(3025159) Blasts/100 leukocytes in Blood

395

3152

1.27

4.85

4.1

4.2

0.07

0.55

1.68

862

(4094501) Cardiovascular stress test using bicycle ergometer

168

1178

1.44

4.83

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

114

739

1.55

4.79

1.5

1.6

—

(40768443) Skin Pathology biopsy report

251

1886

1.35

4.79

1.2

—

(4062490) Immunoglobulin typing, IgG

408

1.75

4.77

1.3

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

4.68

4.67

2.1

2.0

—

(3021440) Promyelocytes/100 leukocytes in Blood

413

3332

1.26

4.64

4.2

4.3

0.10

0.12

0.24

112

1030

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

101

642

1.58

4.64

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

360

1.79

4.63

3.3

3.8

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

139

951

1.47

4.56

2.4

180.11

100.24

ug/min

0.48

574

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

145

1002

1.46

4.52

1.6

1.9

4.39

4.93

iu/l

0.27

378

(3017181) Myelocytes/100 leukocytes in Blood

429

3487

1.25

4.52

4.1

4.2

0.85

0.95

0.38

128

1189

(3019832) Treponema pallidum Ab [Presence] in Serum

356

2832

1.28

4.50

1.8

1.6

—

(3002079) Sodium [Moles/time] in 24 hour Urine

181

2.11

4.46

1.1

1.2

177.76

159.56

mmol/24h

0.35

181

(3020911) Cortisol [Moles/time] in 24 hour Urine

117

2.40

4.46

1.3

1.4

70.81

114.46

nmol/24h

0.98

117

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

152

1068

1.44

4.36

1.2

1.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

519

1.63

4.35

1.3

68.33

59.71

u/ml

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

4.25

4.31

2.1

2.0

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

177

2.10

4.31

1.2

1.1

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

332

1.79

4.29

1.2

1.1

—

19.84

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

171

2.11

4.27

1.2

1.7

2.17

4.68

nmol/l

0.89

143

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

114

763

1.50

4.19

2.5

3.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

335

1.77

4.18

1.3

1.70

1.42

nmol/l

0.78

294

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

228

1.94

4.14

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

128

2.27

4.12

1.4

1.2

—

(3010838) Calcium [Moles/time] in 24 hour Urine

113

759

1.50

4.10

1.8

1.9

5.53

5.17

mmol/24h

0.51

103

660

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

154

1098

1.41

4.10

1.4

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

3.08

4.08

1.4

1.6

—

(3002179) Metamyelocytes/100 leukocytes in Blood

389

3171

1.24

4.02

4.0

4.1

0.66

0.68

0.06

112

1031

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

225

1711

1.33

4.02

1.5

1.8

1.57

1.56

g/l

0.06

189

1472

(3003338) MCHC [Mass/volume]

3903

37674

1.13

3.98

23.6

16.0

332.43

332.34

g/l

0.25

3872

37416

(3012494) Peanut IgE Ab [Units/volume] in Serum

2.54

3.96

1.1

0.11

2.12

u/ml

1.19

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

157

1132

1.40

3.93

1.4

1.3

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.72

3.91

1.1

1.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

359

1.71

3.84

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

322

1.75

3.83

1.2

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

126

878

1.45

3.82

1.5

1.7

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

274

2164

1.28

3.72

9.2

10.1

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

3.83

3.68

1.0

1.2

0.21

0.51

nmol/l

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

160

1174

1.37

3.64

1.6

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

176

1312

1.35

3.62

4.0

3.1

0.37

0.34

u/ml

0.62

744

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

285

1.76

3.55

1.3

1.4

149.80

166.43

pmol/l

0.43

285

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

391

1.64

3.54

1.0

1.1

—

2.05

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

549

1.54

3.51

1.1

2.08

3.33

u/ml

0.84

254

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

5.30

3.50

1.1

1.0

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

2.70

3.48

1.0

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1377

12594

1.13

3.48

4.9

4.8

1.88

3.06

ug/l

3.38

1220

11448

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

258

1.79

3.45

1.0

1.1

2.93

11.70

iu/ml

4.01

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

365

1.65

3.39

1.3

1.5

36.24

32.08

0.31

227

(3019225) pH of Specimen

472

4000

1.20

3.36

3.4

4.3

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

413

1.61

3.34

1.2

1.3

0.44

0.42

g/l

0.16

283

(3028192) IgG subclass 2 [Mass/volume] in Serum

413

1.61

3.34

1.2

1.3

2.72

3.01

g/l

0.78

282

(3027135) IgG subclass 1 [Mass/volume] in Serum

413

1.61

3.34

1.2

1.3

6.25

6.91

g/l

1.10

281

(3047007) Chlamydophila sp Ab [Presence] in Serum

572

1.51

3.34

1.3

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

261

1.77

3.33

1.1

1.3

2.48

1.37

u/ml

0.18

148

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

603

0.53

3.33

1.5

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1122

10159

1.13

3.33

4.5

4.1

21.85

21.70

0.11

491

4923

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

162

1210

1.35

3.32

3.0

2.6

3.64

3.54

g/l

0.31

151

1147

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

115

811

1.43

3.32

2.9

3.9

57.96

57.49

0.14

115

811

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

525

1.53

3.30

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

233

1.81

3.28

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1226

0.67

3.25

1.3

1.5

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

241

1.79

3.25

1.3

1.2

—

(4034850) Laboratory test

182

1389

1.32

3.24

11.9

8.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

4.74

3.23

1.4

1.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

157

1174

1.35

3.21

2.7

2.4

191.43

193.44

0.10

143

1128

(3036489) Thrombin time

201

1558

1.30

3.20

2.1

2.0

21.90

21.53

0.24

177

1363

(3030313) Adrenal Ab [Titer] in Serum

4.51

3.11

1.2

1.0

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

3.67

3.08

1.2

—

(3028717) Thiamine [Mass/volume] in Blood

3.67

3.08

1.3

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.68

3.05

1.3

1.4

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

5.01

3.05

1.1

1.0

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

239

1.76

3.04

1.2

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

10.01

2.98

1.8

2.0

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.40

2.96

1.1

0.55

0.70

umol/24h

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

205

1.81

2.94

2.6

2.0

20.83

119.16

ug/min

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

146

1099

1.34

2.89

2.1

2.0

10.67

11.14

mg/l

0.36

133

1012

(3008898) HLA-B27 [Presence]

171

1320

1.31

2.85

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

267

1.69

2.84

1.0

1.1

222.16

284.87

mg/l

2.79

238

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

275

1.68

2.83

1.1

1.2

34.41

43.32

mg/l

1.15

235

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

208

1.78

2.81

1.9

1.5

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

291

1.66

2.80

1.2

1.0

287.95

287.77

mg/l

0.01

266

(3011648) Oxygen content in Venous blood

315

1.63

2.78

1.6

2.2

11.15

11.12

0.02

315

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

531

1.48

2.77

1.6

1.5

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

540

0.55

2.74

1.8

1.7

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

210

1.77

2.74

1.9

1.5

—

(3032057) Clostridioides difficile [Presence] in Stool

2.37

2.72

1.9

1.8

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

227

2801

0.80

2.71

1.4

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

271

1.67

2.71

1.3

1.6

35.43

19.48

u/ml

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

204

1626

1.26

2.67

3.5

3.7

515.62

3426.86

u/ml

1.00

169

1412

(3050129) First trimester maternal screen panel - Serum or Plasma

820

0.64

2.67

1.5

1.4

—

(3036071) Salmonella sp Ab [Titer] in Serum

147

1.91

2.64

1.1

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

166

1291

1.30

2.64

2.3

2.8

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

258

1.67

2.63

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.66

2.62

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

259

1.67

2.60

1.1

—

(3020491) Glucose [Moles/volume] in Blood

283

1.63

2.57

1.5

1.8

7.99

6.71

mmol/l

0.86

183

(3014271) Vancomycin [Susceptibility]

156

1.86

2.56

3.1

2.4

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.60

2.53

1.0

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

201

1.75

2.51

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

108

2.04

2.51

1.1

1.0

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

194

1.76

2.50

1.1

1.07

1.14

u/l

0.34

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

165

1293

1.28

2.49

2.3

2.1

90.25

91.28

0.20

159

1257

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

453

1.49

2.49

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

294

1.60

2.47

1.8

1.5

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

596

0.60

2.45

2.9

2.6

13.26

13.18

0.22

584

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

203

1.73

2.44

1.6

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

181

1.77

2.43

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

133

1017

1.32

2.42

2.1

3918.03

4836.41

u/l

0.13

425

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

335

1.56

2.42

1.0

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

280

1.61

2.42

1.7

1.6

3.51

6.72

u/l

1.68

235

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

234

1.67

2.41

2.2

1.5

4.63

6.68

u/l

1.77

199

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

522

4594

1.15

2.39

3.6

4.3

38.68

35.72

ug/l

0.05

410

3700

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

2.07

2.36

1.3

1.2

330.27

286.04

pmol/l

0.18

(3005011) Chlamydia sp Ab [Titer] in Serum

2.42

2.36

1.4

1.6

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.61

2.35

1.0

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.50

2.35

1.0

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

484

1.45

2.35

1.4

1.6

53.51

55.64

0.13

312

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.82

2.34

2.0

2.5

—

(3045414) Leukocytes [Presence] in Urine

228

1872

1.23

2.33

1.9

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

448

0.56

2.31

1.3

1.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

245

1.64

2.30

1.9

1.4

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

646

1.38

2.29

1.4

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

155

1.81

2.29

1.1

—

382.05

—

(3016244) Insulin [Units/volume] in Serum or Plasma

185

1.73

2.27

2.7

3.0

21.23

23.94

mu/l

0.27

178

(3048929) Epstein Barr virus Ab [Presence] in Serum

146

1143

1.29

2.26

1.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

674

1.37

2.25

1.6

1.7

—

(3004451) EKG impression Narrative

179

1.74

2.22

1.2

1.3

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.05

2.21

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

100

2.00

2.20

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

525

1.42

2.19

1.1

1.52

1.54

g/l

0.15

468

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

136

1.84

2.17

2.4

2.3

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

138

1080

1.29

2.15

3.1

2.9

1.48

1.55

mg/l

0.52

122

993

(3040151) Glucose [Moles/volume] in Capillary blood

395

1.47

2.13

5.6

4.8

6.54

7.17

mmol/l

1.29

328

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

437

1.45

2.11

1.6

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

102

1.96

2.10

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

397

1.47

2.08

1.1

1.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

284

1.55

2.08

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

253

1.59

2.06

1.1

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

117

1.88

2.05

1.2

2.2

0.62

1.12

ug/l

1.29

106

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

104

1.93

2.00

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.96

1.99

1.3

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

656

1.35

1.97

1.2

18.20

34.11

u/l

2.15

574

(3001556) Androgen free Index in Serum or Plasma

2.97

1.93

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

259

1.55

1.89

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

158

1.71

1.88

1.3

1.6

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

102

784

1.31

1.87

1.5

1.9

0.91

0.82

nmol/l

0.66

672

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.86

1.86

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

416

1.42

1.85

2.4

3.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

367

1.45

1.83

1.3

1.4

67690.62

55238.59

e6/l

0.12

242

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

326

1.48

1.83

1.3

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

326

1.48

1.83

1.3

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

326

1.48

1.83

1.3

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

493

1.38

1.83

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

101

1.88

1.80

5.5

1.2

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.05

1.80

1.0

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

176

1.65

1.79

4.0

4.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

223

1.57

1.78

1.0

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

328

1.47

1.78

1.3

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

328

1.47

1.78

1.3

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

328

1.47

1.78

1.3

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

161

1317

1.23

1.78

1.5

—

(3012565) Volume of 24 hour Urine

200

1.60

1.76

1.7

2.3

1772.93

1909.77

0.42

180

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

765

1.30

1.76

1.2

285.61

279.42

u/ml

0.09

500

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

232

1.56

1.75

1.1

1.3

—

39.00

—

(1761482) Bacteria [#/volume] in Urine by Culture

1043

0.75

1.74

4.7

4.0

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

706

1.31

1.73

1.6

1.4

—

(21494815) CD4 cells/100 lymphocytes in Specimen

331

1.45

1.71

2.2

42.06

38.31

1.00

326

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

103

1.85

1.71

1.1

1.0

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

194

1.60

1.71

1.5

1.8

2.77

3.78

u/field

0.23

124

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

109

858

1.28

1.69

1.1

1.4

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

417

1.40

1.66

2.0

1.8

3104.00

1480.00

titre

—

(3046861) Legionella sp Ag [Presence] in Urine

3.16

1.66

1.3

1.0

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.58

1.65

2.1

1.7

34.38

47.26

umol/l

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

520

1.35

1.65

1.6

1.4

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

624

1.32

1.65

1.0

1.1

5.85

4.68

u/ml

0.20

299

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.80

1.65

1.0

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

572

1.33

1.65

1.7

1.4

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

311

1.45

1.61

1.2

2.80

9.04

u/ml

—

(3038026) Centromere Ab [Units/volume] in Serum

336

1.43

1.60

1.2

—

45.95

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

159

1318

1.21

1.58

1.6

0.98

6.68

iu/ml

0.62

282

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.69

1.58

1.0

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

490

1.35

1.57

1.2

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

490

1.35

1.57

1.2

1.4

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

263

1.49

1.57

2.1

2.5

548.44

552.19

e6/l

0.02

226

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

422

1.38

1.57

4.5

5.4

21.27

94.47

u/ml

2.79

135

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

336

3795

0.88

1.55

1.3

—

(3002619) Bacteria identified in Specimen by Culture

2.03

1.54

1.3

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.03

1.54

1.8

1.6

—

(3050794) Legionella sp Ab [Presence] in Serum

2.43

1.53

1.0

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

216

1.53

1.1

1.2

—

(3008607) Semen analysis panel

3.34

1.52

1.2

1.3

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

169

1.60

1.51

1.2

1.1

137.99

184.07

iu/ml

0.68

169

(3033705) Calcium.ionized [Moles/volume] in Venous blood

479

0.67

1.51

2.4

2.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.16

1.50

1.1

1.0

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

712

0.73

1.50

1.3

1.5

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

187

1584

1.19

1.49

1.8

1.9

—

(3024869) Neuronal Ab [Presence] in Serum

2.07

1.49

1.0

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

454

1.35

1.45

1.0

4.04

3.04

u/ml

0.17

171

(3051651) Icteric interference index of Serum or Plasma

260

1.46

1.45

2.3

3.5

—

(3017509) Phencyclidine [Presence] in Urine

2.50

1.45

2.6

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

922

0.77

1.44

3.3

3.1

27.99

27.72

mg/l

0.02

580

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

2.73

1.43

1.5

1.3

56.90

14.46

pmol/l

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

490

1.33

1.43

1.2

1.4

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

763

1.26

1.43

1.6

1.5

118.07

116.66

u/ml

0.06

165

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

692

1.28

1.43

1.1

0.91

2.15

u/ml

1.90

334

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

371

1.38

1.41

2.3

2.8

—

(21494890) Protein electrophoresis panel - 24 hour Urine

423

1.35

1.39

1.7

2.2

—

(3003694) ABO and Rh group [Type] in Blood

1130

11959

0.93

1.39

1.3

1.4

—

(3004616) Nuclear Ab [Presence] in Serum

510

1.32

1.39

1.3

—

(44813793) Dust mix specific IgE antibody measurement

271

1.44

1.39

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

493

1.32

1.38

1.2

1.4

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

2.00

1.38

2.3

1.8

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

555

1.30

1.37

1.0

1.17

1.63

u/ml

0.36

259

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

503

1.32

1.36

1.2

1.4

—

(3013762) Body weight Measured

2.94

1.36

1.0

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

282

1.42

1.33

2.0

2.1

—

(3016750) Collection duration of Urine

224

1.48

1.33

2.5

2.3

499.95

498.54

min

0.03

167

(3008401) Mugwort IgE Ab [Units/volume] in Serum

593

1.29

1.33

1.0

1.84

1.21

u/ml

0.33

233

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

105

1.72

1.33

1.0

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.97

1.32

1.0

1.1

—

(3035285) Chloride [Moles/volume] in Venous blood

488

0.69

1.32

2.3

2.1

104.15

105.47

mmol/l

0.84

480

(3041354) Potassium [Moles/volume] in Venous blood

488

0.69

1.32

2.3

2.1

4.02

4.05

mmol/l

0.15

480

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

274

2418

1.14

1.32

2.7

3.8

41.27

55.43

u/ml

0.65

264

2329

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

241

1.46

1.32

1.1

1.3

—

290.00

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.50

1.30

1.0

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

499

1.31

1.29

1.2

1.4

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

2.35

1.29

1.4

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

109

892

1.23

1.28

1.4

1.5

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

606

1.27

1.7

1.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

169

1443

1.18

1.27

1.7

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

103

839

1.23

1.27

1.6

1.5

—

(3042631) Mycobacterium sp identified in Specimen

537

1.29

1.25

3.1

2.7

—

(3020393) Adenovirus Ag [Presence] in Stool

2.22

1.24

1.0

—

(3019977) pH of Arterial blood

195

1.49

1.24

2.0

2.1

7.41

7.42

0.22

(3027273) Bicarbonate [Moles/volume] in Venous blood

205

1782

1.16

1.24

3.7

3.2

25.77

25.30

mmol/l

1.12

205

1724

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.86

1.23

1.2

1.3

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

698

1.25

1.23

3.5

2.9

0.81

0.83

nmol/l

0.19

530

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

627

1.26

1.23

1.3

1.2

3.75

4.76

u/ml

0.47

279

(3045424) Erythrocytes [Presence] in Urine

717

1.25

1.22

1.6

1.5

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

2.63

1.21

1.0

1.1

—

22.40

—

(3014051) Protein [Presence] in Urine by Test strip

130

1091

1.20

2.4

2.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

650

0.75

1.20

1.2

1.4

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

140

1.57

1.20

2.5

2.9

7.82

7.69

mg/l

0.03

116

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

145

0.48

1.19

1.0

1.1

—

(3000012) Reticulocyte production index

542

1.28

1.17

2.9

2.2

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

1.16

0.0

4.8

—

(3020874) Milk IgE Ab [Units/volume] in Serum

215

1.44

1.15

1.1

1.93

2.07

u/ml

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

814

1.22

1.14

1.2

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

422

1.31

1.13

1.3

1.4

23927.12

44597.85

e6/l

0.76

238

(3037121) Protein [Mass/volume] in Urine

160

1379

1.17

1.11

3.2

3.1

0.20

0.33

g/l

2.06

570

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

652

0.76

1.10

1.2

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

652

0.76

1.10

1.2

1.4

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

450

1.29

1.10

1.1

95.12

96.57

0.15

425

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.26

1.10

1.0

1.2

12.43

20.39

u/l

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.26

1.10

1.0

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

651

0.77

1.09

1.2

1.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

629

1.24

1.09

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.19

1.08

1.1

1.2

1.47

1.76

umol/24h

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

113

948

1.20

1.08

1.6

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

546

0.75

1.06

1.2

1.5

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.12

1.05

3.0

2.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

113

1.59

1.05

1.3

1.7

10.16

8.77

ug/l

0.52

113

(3022493) Free Hemoglobin [Mass/volume] in Plasma

170

1.47

1.04

5.8

5.3

77.80

60.10

mg/l

0.75

128

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

123

1444

0.85

1.04

1.7

1.9

—

(3017732) Neutrophils [#/volume] in Blood

323

2931

1.11

1.03

2.5

2.8

3.96

5.04

e9/l

2.73

250

2394

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.06

1.02

1.7

2.9

1.29

0.47

u/field

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

179

1.45

1.02

1.0

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

439

0.73

1.01

1.1

1.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

530

0.75

1.01

1.2

1.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

110

928

1.19

1.00

1.6

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

115

1.57

0.99

1.2

1.1

96.17

84.45

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

602

1.23

0.98

1.1

123.27

116.66

0.81

546

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.17

0.98

1.2

1.3

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.97

0.0

4.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

215

1.40

0.97

1.1

1.0

1.22

0.37

u/ml

—

(4146454) Self-monitoring of blood glucose

415

1.28

0.97

2.5

2.6

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.85

0.96

1.3

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

0.00

0.96

0.0

1.1

—

4.74

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

687

1.21

0.94

1.2

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

191

1.42

0.94

1.2

1.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

191

1.42

0.94

1.2

1.7

—

(37021550) Renin [Units/volume] in Plasma --upright

1.61

0.93

1.3

1.4

109.13

51.58

mu/l

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

175

1.43

0.92

1.2

1.1

—

(3010503) CD19 cells [#/volume] in Blood

243

1.36

0.92

2.8

2.4

0.13

0.20

e9/l

0.40

238

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.73

0.92

1.0

1.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

278

1.33

0.91

2.0

1.4

79.41

79.22

umol/l

0.02

278

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

428

1.26

0.91

1.3

1.7

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.63

0.90

1.1

1.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.07

0.89

1.7

1.3

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

786

7457

1.06

0.87

3.1

2.9

0.62

0.76

ug/l

4.16

550

4868

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

494

1.24

0.87

2.4

2.2

14.45

23.90

mg/l

1.30

127

(3005033) Fetal Nuchal fold Thickness US

527

0.78

0.86

1.2

1.4

—

(3036782) Glucose [Moles/volume] in Pleural fluid

369

1.28

0.86

1.3

1.4

6.22

6.31

mmol/l

0.06

341

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

204

1.37

0.85

1.3

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

176

1564

1.13

0.85

1.3

—

(3000330) Specific gravity of Urine by Test strip

187

2092

0.89

0.84

3.4

3.3

—

(4212803) Bone marrow aspirate examination

1.94

0.84

1.0

—

(3003577) Lead [Moles/volume] in Blood

1.94

0.84

1.2

1.4

—

0.12

—

(3020876) Protein [Mass/time] in 24 hour Urine

452

1.24

0.83

1.9

2.4

0.88

1.33

g/24h

0.79

225

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

273

0.69

0.82

1.1

1.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

121

1.49

0.82

2.9

3.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

489

1.23

0.82

1.1

1.0

2.09

2.54

u/ml

0.13

221

(3044009) aPTT.lupus sensitive (LA screen)

1.88

0.81

1.0

1.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

105

1.53

0.81

1.0

—

(3015183) Erythrocyte sedimentation rate

201

0.65

0.81

1.0

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

329

1.28

0.80

1.2

1.3

8.42

8.73

mmol/l

0.18

315

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

106

1.51

0.78

1.1

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

142

1606

0.88

0.78

4.0

5.3

0.89

0.90

0.13

135

1493

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.56

0.78

1.1

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

842

1.17

0.77

1.6

1.4

—

17.93

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

124

0.56

0.77

1.0

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

639

1.19

0.77

1.3

1.2

2.29

3.24

u/ml

0.39

211

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

174

1558

1.12

0.76

2.1

1.9

1.24

2.08

ug/l

0.82

157

1401

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.77

0.76

1.0

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

513

1.21

0.75

1.2

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.84

0.73

1.1

—

(40768793) Breast Pathology biopsy report

122

1073

1.14

0.72

1.4

1.3

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

133

1180

1.13

0.69

1.3

161.20

218.27

miu/ml

1.15

543

(3034860) Kappa light chains.free [Mass/volume] in Serum

139

1237

1.13

0.69

3.0

3.5

48.86

55.93

mg/l

0.24

112

1026

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.85

0.68

1.2

1.3

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

230

2107

1.10

0.68

2.4

2.6

0.25

0.29

e6/l

0.27

223

2062

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

153

1.37

0.66

2.4

2.3

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

451

0.80

0.66

2.1

2.4

—

(3004775) Volume in Urine collected for unspecified duration

321

1.25

0.66

2.5

2.3

779.19

648.44

0.61

210

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

259

1.28

0.65

1.1

—

(3012441) Differential panel - Pleural fluid

395

1.22

0.64

1.2

1.4

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.72

0.64

1.0

1.1

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

1.72

0.64

1.0

1.4

2.84

0.31

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

112

1.43

0.63

1.3

1.2

110.20

84.75

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

146

1618

0.90

0.61

4.0

5.2

1.83

1.62

1.35

140

1502

(3023199) Leukocytes [#/volume] in Pleural fluid

471

1.19

0.61

1.3

1.4

19725.05

1972.57

e6/l

0.51

337

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

1.54

0.59

6.1

5.8

73.13

46.71

ug/min

—

(3045788) Cell count panel - Pleural fluid

372

1.21

0.59

1.4

—

(3037756) Immunofixation for Serum or Plasma

809

1.14

0.58

1.5

1.8

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.58

0.0

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.51

0.58

1.1

1.3

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

137

1236

1.11

0.57

3.0

3.5

28.52

55.56

mg/l

1.80

110

1024

(3008536) Aspergillus sp Ab [Presence] in Serum

0.57

0.56

1.2

2.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

224

2075

1.08

0.55

1.9

1.7

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

133

1202

1.11

0.55

3.0

3.5

1.17

2.25

ratio

—

112

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.50

0.54

1.3

1.5

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

524

1.17

0.54

2.8

2.1

2.50

11.93

titre

—

(3006462) Nitrate [Presence] in Urine

204

1.28

0.54

2.8

3.4

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.54

0.53

1.0

2.3

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

100

1.40

0.51

1.3

37.11

36.81

—

(3009871) Measles virus Ab [Titer] in Serum

161

1.31

0.51

1.7

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

398

1.18

0.50

1.0

1.09

0.34

u/ml

0.31

100

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

153

1.31

0.50

1.0

—

(3003434) Protein [Mass/volume] in Pleural fluid

529

1.15

0.49

1.3

1.5

35.98

33.10

g/l

1.05

477

(3024263) Appearance of Synovial fluid

216

1.25

0.49

1.2

1.3

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.43

0.49

1.5

1.3

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

700

1.13

0.47

1.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.49

0.47

1.1

—

(3048879) Bone marrow aspiration report

120

0.67

0.45

1.1

2.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

283

1.20

0.44

1.4

1.5

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

1.45

0.44

1.0

6.27

9.11

mg/g

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.37

0.44

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.37

0.44

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.37

0.44

1.3

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

340

1.18

0.43

1.4

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

340

1.18

0.43

1.4

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

340

1.18

0.43

1.4

1.7

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

151

0.73

0.42

1.0

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

122

1.31

0.42

2.1

1.8

—

(3022689) Creatine [Moles/volume] in Urine

131

1.30

0.42

1.1

1.5

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

185

1.24

0.41

1.1

1495.43

1526.46

miu/ml

0.05

185

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

1.1

—

294.13

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.41

0.0

1.2

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.41

0.0

5.7

—

400.53

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.1

—

(3018572) Chloride [Moles/volume] in Blood

899

0.90

0.40

4.8

7.4

105.99

105.33

mmol/l

0.72

794

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.47

0.40

1.0

1.1

—

(3039000) Anion gap in Blood

898

0.90

0.40

4.8

7.4

10.84

11.20

mmol/l

0.59

793

(3017704) Immunofixation for Urine

216

0.79

0.40

1.9

1.6

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.40

0.0

1.1

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

0.00

0.39

0.0

1.6

—

2.08

—

(3033799) Differential panel - Peritoneal fluid

148

0.74

0.38

1.7

1.8

—

(3001729) Color of Synovial fluid

1.35

0.37

1.0

1.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

686

1.11

0.37

1.3

1.7

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

125

1.28

0.36

2.6

1.8

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

198

1.21

0.36

1.0

2.33

1.85

u/ml

—

(1617658) Protocol used for examination of sentinel lymph nodes

364

0.85

0.36

1.0

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

1.27

0.36

1.0

1.5

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

168

0.77

0.35

1.2

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

339

1.15

0.34

1.3

2.1

4.85

8.89

umol/l

1.38

239

(40768446) Kidney Pathology biopsy report

163

1.23

0.34

1.2

1.7

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.30

0.33

1.0

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

0.68

0.33

1.3

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

242

0.83

0.32

1.0

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

143

0.77

0.32

1.0

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

137

1.24

0.32

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

241

0.83

0.31

1.1

1.4

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

164

0.79

0.30

1.1

1.4

—

(3000034) Microalbumin [Mass/volume] in Urine

400

0.87

0.30

3.6

3.0

10.85

69.96

mg/l

2.24

289

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.25

0.29

1.6

2.5

—

(3006576) Bicarbonate [Moles/volume] in Blood

141

0.78

0.29

2.7

6.4

26.17

25.18

mmol/l

0.18

130

(3042733) HLA Ab [Presence] in Serum

148

1.22

0.29

4.2

5.3

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

460

0.89

0.28

3.8

3.5

22.54

44.96

u/ml

2.71

455

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

393

1.12

0.28

1.3

1.8

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.29

0.28

1.1

1.5

—

106.80

titre

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

346

1.13

0.27

1.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

101

942

1.07

0.27

3.0

3.6

296.06

387.43

u/ml

0.20

854

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

104

1.25

0.26

1.5

2.0

1.48

2.40

ug/l

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

521

5351

0.97

0.26

4.6

4.4

31.02

32.85

3.51

372

3661

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

255

0.86

0.24

1.1

1.12

1.05

ratio

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

1.32

0.23

2.0

1.8

1.54

1.85

mg/l

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.25

0.22

1.2

1.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

1.19

0.21

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.21

0.0

13.1

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.21

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.21

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.21

0.0

2.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.6

—

1.95

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

0.00

0.21

0.0

10.0

—

60.60

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.21

0.0

1.0

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

344

1.11

0.21

1.6

1.4

2.74

4.72

ug/l

1.09

273

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

335

0.89

0.20

1.6

—

(40760888) Immunoglobulin light chains.free panel - Serum

934

0.94

0.20

3.2

3.6

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.25

0.20

1.2

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

737

0.94

0.19

1.4

1.6

—

(21494814) CD8 cells/100 lymphocytes in Specimen

165

1.15

0.19

2.6

2.0

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

204

1.13

0.18

2.4

2.3

214.39

202.24

u/l

0.20

204

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

116

1108

1.05

0.17

1.3

—

(3043410) Blood group antigens tested for on Red Blood Cells

110

1.18

0.17

1.5

2.0

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.11

0.17

1.3

30.03

49.87

mg/l

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

0.72

0.16

3.2

2.7

—

(40768795) Lymph node Pathology biopsy report

464

0.93

0.16

1.3

1.2

—

(3044927) Protein electrophoresis panel - Urine

408

1.08

0.16

1.3

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.11

0.16

1.3

1.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

623

1.06

0.15

1.1

1.13

1027.79

iu/ml

0.59

137

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

119

0.84

0.15

1.2

2.0

15.58

50.02

u/l

—

111

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

102

1.18

0.15

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

102

1.18

0.15

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

102

1.18

0.15

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

102

1.18

0.15

1.2

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.11

0.15

1.0

1.1

—

(4035726) Immunohistochemistry procedure

415

4072

1.02

0.14

1.3

1.4

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

148

0.88

0.12

1.6

1.8

366.83

26324.39

e6/l

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

570

1.05

0.12

1.3

1.2

7.69

7.42

mmol/l

0.29

500

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

104

1.15

0.12

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

133

1.13

0.12

1.3

1.4

—

(21494434) Karyotype in Bone marrow

364

0.93

0.11

1.1

1.2

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

199

0.90

0.11

1.3

1.5

9.95

7.93

mmol/l

1.64

194

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

182

1.10

0.11

1.1

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

182

1.10

0.11

1.1

1.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

192

1.09

0.10

1.8

3.3

—

(40768806) Pleura Pathology biopsy report

417

1.06

0.10

1.3

1.5

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

156

0.90

0.10

1.1

1.8

—

(40768800) Prostate Pathology biopsy report

799

0.96

0.10

1.2

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

447

1.05

0.10

2.6

2.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.04

0.09

1.4

1.5

—

(40768441) Liver Pathology biopsy report

321

1.06

0.09

1.6

1.3

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.05

0.08

1.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

107

1.12

0.08

1.8

2.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

107

1.12

0.08

1.8

2.3

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

410

1.05

0.08

1.6

1.3

—

(3013727) Leukocytes other/100 leukocytes in Blood

144

0.90

0.08

2.8

3.5

50.26

51.01

0.04

135

(3020650) Glucose [Presence] in Urine

123

0.89

0.08

1.5

1.3

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

0.83

0.07

1.8

1.6

101.78

146.78

ng/l

—

(40758292) HTLV I+II Ab panel - Serum

0.82

0.07

1.0

1.5

—

(40757373) Influenza virus identified in Isolate

1.07

0.07

1.4

1.6

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

236

1.06

0.06

2.9

2.8

36.31

39.63

0.39

129

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

101

0.89

0.06

4.2

2.2

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

1.11

0.05

2.2

3.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

1.11

0.05

4.4

6.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

653

1.03

0.05

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

317

1.04

0.05

1.2

—

(3044007) Cell count panel - Peritoneal fluid

130

0.92

0.04

1.9

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

209

1.05

0.04

1.3

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

219

1.05

0.04

9.0

5.1

35.60

17487.26

u/ml

—

(3004809) Band form neutrophils/100 leukocytes in Blood

675

0.98

0.04

3.6

3.7

1.65

1.57

0.05

599

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

239

1.05

0.04

1.1

1.4

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

101

1.09

0.04

1.1

1.4

17.76

21.04

0.28

(3022621) pH of Urine by Test strip

274

2717

1.01

0.04

3.2

2.8

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

271

0.96

0.04

1.0

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

279

1.04

0.04

1.5

1.7

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

458

1.03

0.03

1.4

1.5

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

458

1.03

0.03

1.4

1.5

—

(3045142) Bone marrow Pathology biopsy report

498

1.02

0.03

1.2

1.4

—

(3047181) Lactate [Moles/volume] in Blood

127

1255

1.01

0.03

4.1

6.3

1.16

1.28

mmol/l

1.65

116

1095

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

102

1.08

0.03

1.4

1.5

—

55.63

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

122

1.07

0.02

1.4

1.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

660

1.02

0.02

1.4

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

660

1.02

0.02

1.4

1.6

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

153

1.05

0.01

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

167

0.96

0.01

1.1

—

(40765096) Chromosome analysis panel by Banding

126

0.95

0.00

1.2

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

234

1.03

0.00

1.1

1.4

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

886

0.99

0.00

3.8

5.7

131.50

506.24

iu/ml

—

123

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

102

0.98

0.00

1.1

—

(3034426) Prothrombin time (PT)

152

0.99

0.00

1.2

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

162

0.99

0.00

1.6

2.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

178

1.01

0.00

2.9

2.7

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

298

1.01

0.00

1.1

1.3

1.57

g/l

0.02

298

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

103

0.97

0.00

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

204

0.98

0.00

1.5

2.0

—

(3028433) Virus identified in Specimen by Culture

133

0.98

0.00

1.1

1.2

—

(3024932) HLA-DR beta [Type]

147

1.02

0.00

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

163

0.98

0.00

1.3

1.5

—

(3051593) INR in Capillary blood by Coagulation assay

173

0.98

0.00

12.2

12.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

203

0.99

0.00

1.5

2.0

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

404

0.99

0.00

4.1

3.9

57.55

56.74

0.08

349

(3035880) pH of Pleural fluid

217

1.01

0.00

1.5

1.3

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

426

1.01

0.00

4.5

4.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

313

0.99

0.00

7.7

6.6

—

(3003740) Influenza virus B Ag [Presence] in Specimen

657

1.00

0.00

1.2

1.1

—

(3024471) HLA-A [Type]

151

0.99

0.00

1.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

159

1.01

0.00

1.6

2.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

159

1.01

0.00

1.6

2.2

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

161

0.99

0.00

1.5

2.0

37677.00

5597.10

e6/l

—

111

(3047189) Immunofixation for 24 hour Urine

189

1.01

0.00

1.3

2.0

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

319

1.00

0.00

1.6

1.9

2.44

1.91

u/field

0.22

112

(4281824) Cell count and differential, peritoneal fluid

541

1.00

0.00

1.0

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

0.96

0.00

1.0

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.94

0.00

1.0

1.1

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

0.96

0.00

1.2

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.99

0.00

2.0

3.0

—

(3014891) Appearance of Pleural fluid

0.91

0.00

1.0

1.3

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.00

-0.00

1.0

1.3

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

-0.00

0.0

2.4

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

0.90

-0.00

1.3

1.2

—

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.7

—

38.00

—

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

13.99

—

(3009992) Blasts/100 cells in Bone marrow

0.00

-0.00

0.0

2.4

—

2.86

—

(3051671) S100 calcium binding protein B [Mass/volume] in Serum

0.00

-0.00

0.0

2.3

—

0.07

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.1

—

1.10

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

0.00

-0.00

0.0

1.0

—

1.00

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

-0.00

0.0

1.0

—

(3014171) Thiocyanate [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

120.60

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

-0.00

0.0

1.1

—

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

-0.00

0.0

1.1

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

-0.00

0.0

1.1

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

-0.00

0.0

1.0

—

0.44

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: MAOI_A – Monoamine oxidase A inhibitors

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Monoamine oxidase A inhibitors

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Case counts by code for Monoamine oxidase A inhibitors (MAOI_A)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints